journal,year,volume,issue,DOI,SI,event,date
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010001,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2015-10-12
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010001,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2015-11-18
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010001,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2015-11-20
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010001,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2015-12-26
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010002,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2015-10-27
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010002,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2016-01-05
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010002,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2016-01-07
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010002,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2016-01-13
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010003,"
(This article belongs to the Special Issue Chemotherapeutic Agents)","
Received",2015-11-11
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010003,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Revised,2015-12-29
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010003,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Accepted,2016-01-06
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010003,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Published,2016-01-14
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010004,"
(This article belongs to the Special Issue Chemotherapeutic Agents)","
Received",2015-11-30
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010004,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Revised,2016-01-07
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010004,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Accepted,2016-01-14
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010004,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Published,2016-01-19
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010005,Normal Issue,"
Received",2016-01-21
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010005,Normal Issue, Accepted,2016-01-21
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010005,Normal Issue, Published,2016-01-21
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010006,Normal Issue,"
Received",2016-01-23
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010006,Normal Issue, Accepted,2016-01-25
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010006,Normal Issue, Published,2016-01-27
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010007,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-01-14
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010007,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-01-31
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010007,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-02-02
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010007,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-02-05
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010008,Normal Issue,"
Received",2015-12-17
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010008,Normal Issue, Revised,2016-01-27
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010008,Normal Issue, Accepted,2016-01-29
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010008,Normal Issue, Published,2016-02-06
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010009,Normal Issue,"
Received",2015-12-04
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010009,Normal Issue, Revised,2016-01-28
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010009,Normal Issue, Accepted,2016-02-01
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010009,Normal Issue, Published,2016-02-17
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010010,Normal Issue,"
Received",2015-06-12
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010010,Normal Issue, Revised,2015-09-08
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010010,Normal Issue, Accepted,2016-02-22
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010010,Normal Issue, Published,2016-02-25
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010011,"
(This article belongs to the Special Issue Chemotherapeutic Agents)","
Received",2015-12-03
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010011,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Revised,2016-02-08
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010011,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Accepted,2016-02-16
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010011,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Published,2016-02-25
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010012,"
(This article belongs to the Special Issue Chemotherapeutic Agents)","
Received",2016-01-13
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010012,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Revised,2016-02-19
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010012,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Accepted,2016-03-08
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010012,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Published,2016-03-10
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010013,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-01-25
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010013,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-03-01
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010013,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-03-03
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010013,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-03-11
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010014,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-03-04
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010014,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-03-07
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010014,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-03-11
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010015,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)","
Received",2016-02-23
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010015,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Accepted,2016-02-26
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010015,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Published,2016-03-17
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010016,"
(This article belongs to the Special Issue Microbial Biofilms)","
Received",2016-01-05
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010016,"
(This article belongs to the Special Issue Microbial Biofilms)", Revised,2016-03-12
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010016,"
(This article belongs to the Special Issue Microbial Biofilms)", Accepted,2016-03-15
Pharmaceuticals,2016,9,1,https://doi.org/10.3390/ph9010016,"
(This article belongs to the Special Issue Microbial Biofilms)", Published,2016-03-17
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020017,Normal Issue,"
Received",2015-11-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020017,Normal Issue, Revised,2016-03-15
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020017,Normal Issue, Accepted,2016-03-16
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020017,Normal Issue, Published,2016-03-23
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020018,"
(This article belongs to the Special Issue Chemotherapeutic Agents)","
Received",2016-01-04
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020018,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Revised,2016-03-11
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020018,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Accepted,2016-03-16
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020018,"
(This article belongs to the Special Issue Chemotherapeutic Agents)", Published,2016-03-24
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020019,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2015-12-21
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020019,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-03-29
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020019,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-04-01
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020019,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-04-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020020,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-02-11
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020020,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-04-08
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020020,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-04-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020020,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-04-19
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020021,"
(This article belongs to the Special Issue Antidepressants: Current Progress and Future Prospects)","
Received",2015-12-31
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020021,"
(This article belongs to the Special Issue Antidepressants: Current Progress and Future Prospects)", Revised,2016-04-14
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020021,"
(This article belongs to the Special Issue Antidepressants: Current Progress and Future Prospects)", Accepted,2016-04-18
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020021,"
(This article belongs to the Special Issue Antidepressants: Current Progress and Future Prospects)", Published,2016-05-03
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020022,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)","
Received",2016-03-11
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020022,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Revised,2016-04-12
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020022,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Accepted,2016-04-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020022,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Published,2016-04-21
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020023,Normal Issue,"
Received",2016-03-24
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020023,Normal Issue, Revised,2016-04-21
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020023,Normal Issue, Accepted,2016-04-25
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020023,Normal Issue, Published,2016-04-28
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020024,Normal Issue,"
Received",2016-03-03
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020024,Normal Issue, Revised,2016-04-23
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020024,Normal Issue, Accepted,2016-04-28
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020024,Normal Issue, Published,2016-05-06
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020025,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)","
Received",2016-04-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020025,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Revised,2016-05-06
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020025,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Accepted,2016-05-09
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020025,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Published,2016-05-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020026,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2016-01-27
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020026,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2016-05-03
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020026,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2016-05-10
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020026,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2016-05-16
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020027,Normal Issue,"
Received",2016-03-07
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020027,Normal Issue, Revised,2016-05-12
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020027,Normal Issue, Accepted,2016-05-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020027,Normal Issue, Published,2016-05-19
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020028,"
(This article belongs to the Special Issue New Drugs in Hematology)","
Received",2016-03-29
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Revised,2016-05-03
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Accepted,2016-05-12
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Published,2016-05-19
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020029,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-02-20
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020029,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2016-05-09
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020029,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2016-05-10
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020029,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2016-05-19
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020030,Normal Issue,"
Received",2016-02-17
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020030,Normal Issue, Revised,2016-05-16
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020030,Normal Issue, Accepted,2016-05-19
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020030,Normal Issue, Published,2016-05-25
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020031,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)","
Received",2016-04-20
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020031,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Revised,2016-05-30
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020031,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Accepted,2016-06-01
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020031,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Published,2016-06-06
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020032,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-04-29
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020032,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-06-03
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020032,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-06-07
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020032,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-06-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020033,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2015-12-28
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020033,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2016-06-13
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020033,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2016-06-14
Pharmaceuticals,2016,9,2,https://doi.org/10.3390/ph9020033,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2016-06-16
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030034,Normal Issue,"
Received",2016-03-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030034,Normal Issue, Revised,2016-06-03
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030034,Normal Issue, Accepted,2016-06-20
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030034,Normal Issue, Published,2016-06-24
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030035,Normal Issue,"
Received",2016-06-22
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030035,Normal Issue, Revised,2016-06-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030035,Normal Issue, Accepted,2016-06-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030035,Normal Issue, Published,2016-06-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030036,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-05-19
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030036,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-06-15
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030036,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-06-17
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030036,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-06-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030037,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)","
Received",2016-04-22
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030037,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Revised,2016-06-15
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030037,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Accepted,2016-06-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030037,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Published,2016-06-29
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030038,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)","
Received",2016-05-29
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030038,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Revised,2016-06-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030038,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Accepted,2016-06-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030038,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Published,2016-07-04
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030039,Normal Issue,"
Received",2016-05-13
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030039,Normal Issue, Revised,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030039,Normal Issue, Accepted,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030039,Normal Issue, Published,2016-07-04
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030040,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-06-02
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030040,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-06-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030040,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030040,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-07-04
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030041,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-05-26
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030041,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-06-29
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030041,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030041,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-07-05
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030042,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)","
Received",2016-04-20
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030042,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Revised,2016-06-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030042,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Accepted,2016-07-01
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030042,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Published,2016-07-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030043,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)","
Received",2016-05-12
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030043,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Revised,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030043,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Accepted,2016-07-01
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030043,"
(This article belongs to the Special Issue Selected Papers from the 1st International Electronic Conference on Medicinal Chemistry)", Published,2016-07-08
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030044,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-05-26
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030044,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-06-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030044,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-07-04
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030044,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-07-09
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030045,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-06-01
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030045,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-07-12
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030045,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-07-22
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030045,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-07-28
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030046,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-05-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030046,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-06-19
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030046,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-07-25
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030046,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-07-28
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030047,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-06-01
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030047,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-08-04
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030047,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-08-09
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030047,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-08-11
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030048,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)","
Received",2016-06-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030048,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Revised,2016-08-05
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030048,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Accepted,2016-08-08
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030048,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Published,2016-08-12
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030049,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)","
Received",2016-05-30
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030049,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Revised,2016-08-08
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030049,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Accepted,2016-08-08
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030049,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Published,2016-08-18
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030050,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-06-03
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030050,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-08-10
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030050,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-08-11
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030050,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-08-17
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030051,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)","
Received",2016-07-25
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030051,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Revised,2016-08-03
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030051,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Accepted,2016-08-10
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030051,"
(This article belongs to the Special Issue New Challenges in Radiochemistry)", Published,2016-08-17
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030052,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-07-13
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030052,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-08-12
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030052,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-08-18
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030052,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-08-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030053,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-06-28
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030053,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-08-25
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030053,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-08-31
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030053,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-09-06
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030054,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)","
Received",2016-07-13
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030054,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Revised,2016-08-15
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030054,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Accepted,2016-08-24
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030054,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Published,2016-09-08
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030055,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-07-01
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030055,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-08-19
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030055,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-08-31
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030055,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-09-09
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030056,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-05-27
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030056,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-08-17
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030056,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-08-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030056,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-09-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030057,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-05-23
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030057,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-08-05
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030057,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-09-05
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030057,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-09-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030058,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)","
Received",2016-07-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030058,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Revised,2016-08-31
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030058,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Accepted,2016-09-03
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030058,"
(This article belongs to the Special Issue Grand Celebration: 100th Anniversary of the Discovery of Heparin)", Published,2016-09-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030059,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-07-22
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030059,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-09-07
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030059,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-09-13
Pharmaceuticals,2016,9,3,https://doi.org/10.3390/ph9030059,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-09-20
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040060,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-07-06
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040060,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-09-14
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040060,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-10-05
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040061,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)","
Received",2016-07-29
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040061,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Revised,2016-09-15
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040061,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Accepted,2016-09-21
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040061,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Published,2016-09-27
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040062,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)","
Received",2016-08-24
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040062,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Revised,2016-09-23
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040062,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Accepted,2016-09-26
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040062,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Published,2016-09-29
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040063,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)","
Received",2016-08-03
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040063,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Revised,2016-10-12
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040063,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Accepted,2016-10-13
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040063,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Published,2016-10-18
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040064,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-08-29
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040064,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2016-09-29
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040064,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2016-10-19
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040064,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2016-10-24
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040065,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)","
Received",2016-09-07
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040065,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Revised,2016-10-24
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040065,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Accepted,2016-10-26
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040065,"
(This article belongs to the Special Issue Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health)", Published,2016-10-29
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040066,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-09-07
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040066,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-10-25
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040066,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-10-27
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040066,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-11-01
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040067,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)","
Received",2016-07-05
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040067,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Revised,2016-10-25
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040067,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Accepted,2016-10-26
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040067,"
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)", Published,2016-11-01
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040068,Normal Issue,"
Received",2016-05-13
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040068,Normal Issue, Revised,2016-10-24
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040068,Normal Issue, Accepted,2016-10-25
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040068,Normal Issue, Published,2016-11-01
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040069,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-10-05
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040069,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2016-10-27
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040069,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2016-10-28
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040069,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2016-11-03
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040070,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-07-14
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040070,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-09-23
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040070,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-09-28
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040070,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-11-05
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040071,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)","
Received",2016-08-18
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040071,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Revised,2016-11-02
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040071,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Accepted,2016-11-02
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040071,"
(This article belongs to the Special Issue Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal)", Published,2016-11-10
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040072,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-08-24
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040072,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-11-07
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040072,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-11-09
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040072,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-11-14
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040073,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2016-11-08
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040073,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2016-11-10
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040073,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2016-11-18
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040074,Normal Issue,"
Received",2016-08-25
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040074,Normal Issue, Revised,2016-11-15
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040074,Normal Issue, Accepted,2016-11-22
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040074,Normal Issue, Published,2016-11-26
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040075,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)","
Received",2016-08-17
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040075,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Revised,2016-11-21
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040075,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Accepted,2016-11-22
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040075,"
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)", Published,2016-11-30
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040076,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-11-15
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040076,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2016-12-06
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040076,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2016-12-07
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040076,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2016-12-10
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040077,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2016-10-25
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040077,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2016-12-08
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040077,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2016-12-09
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040077,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2016-12-14
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040078,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-10-13
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040078,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2016-12-12
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040078,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2016-12-13
Pharmaceuticals,2016,9,4,https://doi.org/10.3390/ph9040078,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2016-12-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010001,Normal Issue,"
Received",2016-12-11
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010001,Normal Issue, Revised,2016-12-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010001,Normal Issue, Accepted,2016-12-22
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010001,Normal Issue, Published,2016-12-26
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010002,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-24
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010002,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2016-12-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010002,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2016-12-23
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010002,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2016-12-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010003,Normal Issue,"
Received",2016-10-04
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010003,Normal Issue, Revised,2016-12-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010003,Normal Issue, Accepted,2016-12-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010003,Normal Issue, Published,2016-12-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010004,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-29
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010004,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2016-12-12
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010004,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2016-12-19
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010004,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2016-12-29
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010005,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-01
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010005,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2016-12-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010005,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2016-12-22
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010005,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-01
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010006,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-30
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010006,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2016-12-24
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010006,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2016-12-27
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010006,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-05
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010007,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-30
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010007,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2016-12-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010007,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2016-12-30
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010007,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-05
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010008,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010008,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-03
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010008,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-04
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010008,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-09
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010009,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-01
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010009,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-03
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010009,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-05
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010009,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-11
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010010,Normal Issue,"
Received",2017-01-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010010,Normal Issue, Revised,2017-01-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010010,Normal Issue, Accepted,2017-01-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010010,Normal Issue, Published,2017-01-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010011,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010011,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-12
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010011,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010011,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010012,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2016-12-07
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010012,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-01-09
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010012,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-01-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010012,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-01-19
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010013,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-03
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010013,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010013,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-14
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010013,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-19
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010014,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2016-11-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010014,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Revised,2017-01-12
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010014,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2017-01-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010014,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2017-01-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010015,Normal Issue,"
Received",2016-11-01
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010015,Normal Issue, Revised,2017-01-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010015,Normal Issue, Accepted,2017-01-17
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010015,Normal Issue, Published,2017-01-24
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010016,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-25
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010016,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010016,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-22
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010016,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-03
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010017,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2016-12-12
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010017,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2017-01-17
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010017,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-01-17
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010017,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-01-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010018,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-02
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010018,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-23
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010018,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-01-23
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010018,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-01-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010019,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2016-12-02
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010019,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2017-01-23
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010019,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-01-23
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010019,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-01-28
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010020,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-01-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010020,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-01-24
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010020,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-01-31
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010021,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-30
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010021,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-27
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010021,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-02-04
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010021,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-07
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010022,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-29
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010022,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-01-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010022,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-02-07
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010022,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-09
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010023,Normal Issue,"
Received",2017-01-03
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010023,Normal Issue, Accepted,2017-02-06
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010023,Normal Issue, Published,2017-02-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010024,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-11-30
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010024,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-02-01
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010024,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-02-06
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010024,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-12
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010025,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-07
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010025,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-02-06
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010025,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-02-14
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010025,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-21
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010026,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2016-12-15
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010026,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-02-14
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010026,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-02-20
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010027,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2017-01-14
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010027,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-02-25
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010027,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-03-02
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010027,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-03-05
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010028,"
(This article belongs to the Special Issue New Drugs in Hematology)","
Received",2017-01-27
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Revised,2017-03-06
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Accepted,2017-03-08
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010028,"
(This article belongs to the Special Issue New Drugs in Hematology)", Published,2017-03-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010029,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-01-31
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010029,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-03-08
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010029,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-03-10
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010030,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-02-07
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010030,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-03-08
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010030,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-03-09
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010030,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-03-15
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010031,Normal Issue,"
Received",2017-01-04
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010031,Normal Issue, Revised,2017-03-02
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010031,Normal Issue, Accepted,2017-03-09
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010031,Normal Issue, Published,2017-03-16
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010032,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)","
Received",2017-03-13
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010032,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Accepted,2017-03-14
Pharmaceuticals,2017,10,1,https://doi.org/10.3390/ph10010032,"
(This article belongs to the Special Issue Aptamers: Biomedical Interest and Applications)", Published,2017-03-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020033,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)","
Received",2017-03-20
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020033,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Revised,2017-03-21
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020033,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Accepted,2017-03-21
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020033,"
(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)", Published,2017-03-23
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020034,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-02-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020034,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-03-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020034,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-03-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020034,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-03-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020035,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2017-01-30
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020035,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2017-03-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020035,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2017-03-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020035,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2017-03-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020036,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-01-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020036,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-03-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020036,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-03-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020036,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-03-29
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020037,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2017-02-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020037,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2017-03-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020037,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2017-03-23
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020037,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2017-03-30
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020038,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-02-26
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020038,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-03-28
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020038,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-03-30
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020038,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-04-01
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020039,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2017-01-02
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020039,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2017-02-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020039,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2017-03-29
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020039,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2017-04-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020040,"
(This article belongs to the Special Issue New Drugs in Hematology)","
Received",2017-02-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020040,"
(This article belongs to the Special Issue New Drugs in Hematology)", Revised,2017-03-28
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020040,"
(This article belongs to the Special Issue New Drugs in Hematology)", Accepted,2017-04-04
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020040,"
(This article belongs to the Special Issue New Drugs in Hematology)", Published,2017-04-11
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020041,"
(This article belongs to the Special Issue Metal-Based Drugs)","
Received",2016-12-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020041,"
(This article belongs to the Special Issue Metal-Based Drugs)", Revised,2017-03-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020041,"
(This article belongs to the Special Issue Metal-Based Drugs)", Accepted,2017-03-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020041,"
(This article belongs to the Special Issue Metal-Based Drugs)", Published,2017-04-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020042,"
 (This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-02-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020042,"
 (This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-03-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020042,"
 (This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-04-12
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020042,"
 (This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-04-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2017-04-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2017-04-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2017-04-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2017-04-30
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020044,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-03-03
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020044,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-04-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020044,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-04-26
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020044,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-05-04
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020045,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-02-14
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020045,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-05-03
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020045,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-05-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020045,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-05-18
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020046,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-04-03
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020046,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-05-12
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020046,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-05-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020046,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-05-18
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020047,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-04-29
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020047,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Revised,2017-05-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020047,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-05-16
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020047,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-05-18
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020048,Normal Issue,"
Received",2017-05-19
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020048,Normal Issue, Revised,2017-05-19
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020048,Normal Issue, Accepted,2017-05-19
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020048,Normal Issue, Published,2017-05-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020049,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-05-08
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020049,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-05-24
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020049,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-05-28
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020049,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-05-30
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020050,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-04-22
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020050,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Revised,2017-05-25
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020050,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-05-27
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020050,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-05-31
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020051,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-04-04
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020051,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Revised,2017-05-09
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020051,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-05-29
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020051,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-06-01
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020052,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2017-05-08
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020052,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2017-06-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020052,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2017-06-06
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020052,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2017-06-09
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020053,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-04-28
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020053,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-06-07
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020053,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-06-09
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020053,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-06-13
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020054,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-05-04
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020054,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-06-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020054,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-06-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020054,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-06-13
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020055,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-05-11
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020055,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-06-13
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020055,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-06-14
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020055,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-06-21
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020056,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-04-25
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020056,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-06-13
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020056,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-06-15
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020056,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-06-20
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020057,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-05-05
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020057,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-06-11
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020057,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-06-12
Pharmaceuticals,2017,10,2,https://doi.org/10.3390/ph10020057,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-06-21
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030058,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-05-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030058,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2017-06-22
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030058,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-06-23
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030058,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-06-25
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030059,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-06-08
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030059,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-06-28
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030059,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-06-29
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030059,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-07-02
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030060,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-06-14
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030060,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-06-30
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030060,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-07-03
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030060,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-07-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030061,Normal Issue,"
Received",2017-07-03
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030061,Normal Issue, Revised,2017-07-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030061,Normal Issue, Accepted,2017-07-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030061,Normal Issue, Published,2017-07-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030062,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-05-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030062,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Revised,2017-06-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030062,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-06-27
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030062,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-07-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030063,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-05-10
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030063,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-06-13
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030063,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-07-01
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030063,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-07-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030064,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)","
Received",2017-06-25
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030064,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Revised,2017-06-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030064,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Accepted,2017-06-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030064,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts)", Published,2017-07-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030065,Normal Issue,"
Received",2016-11-25
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030065,Normal Issue, Revised,2017-02-19
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030065,Normal Issue, Accepted,2017-07-16
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030065,Normal Issue, Published,2017-07-20
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030066,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-05-01
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030066,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-07-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030066,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-07-19
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030066,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-07-22
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030067,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-05-15
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030067,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-07-26
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030067,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-07-27
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030067,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-07-30
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030068,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-05-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030068,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-07-13
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030068,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-07-25
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030068,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-07-31
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030069,Normal Issue,"
Received",2017-06-12
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030069,Normal Issue, Revised,2017-07-27
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030069,Normal Issue, Accepted,2017-07-29
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030069,Normal Issue, Published,2017-08-01
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030070,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-07-01
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030070,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-07-24
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030070,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-07-24
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030070,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-08-09
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030071,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)","
Received",2017-04-30
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030071,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Revised,2017-08-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030071,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Accepted,2017-08-07
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030071,"
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)", Published,2017-08-09
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030072,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-05-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030072,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-07-31
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030072,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-08-09
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030072,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-08-15
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030073,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-07-06
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030073,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-08-14
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030073,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-08-16
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030073,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-08-18
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030074,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-06-11
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030074,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2017-08-28
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030074,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-08-30
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030074,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-09-05
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030075,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-08-21
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030075,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-09-07
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030075,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-09-09
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030075,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-09-13
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030076,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-08-18
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030076,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-09-13
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030076,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-09-15
Pharmaceuticals,2017,10,3,https://doi.org/10.3390/ph10030076,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-09-20
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040077,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)","
Received",2017-08-15
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040077,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Revised,2017-09-14
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040077,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Accepted,2017-09-16
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040077,"
(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)", Published,2017-09-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040078,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2017-07-05
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040078,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2017-09-21
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040078,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2017-09-22
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040078,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2017-10-02
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040079,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-08-28
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040079,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-09-29
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040079,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-09-29
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040079,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-10-08
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040080,Normal Issue,"
Received",2017-09-05
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040080,Normal Issue, Revised,2017-09-26
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040080,Normal Issue, Accepted,2017-10-06
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040080,Normal Issue, Published,2017-10-12
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040081,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2017-08-21
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040081,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2017-10-09
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040081,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2017-10-15
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040081,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2017-10-16
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040082,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-09-26
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040082,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-10-17
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040082,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-10-19
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040082,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-10-20
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040083,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-09-07
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040083,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-10-17
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040083,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-10-22
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040083,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-10-24
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040084,Normal Issue,"
Received",2017-09-19
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040084,Normal Issue, Revised,2017-10-24
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040084,Normal Issue, Accepted,2017-10-25
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040084,Normal Issue, Published,2017-10-31
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040085,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-09-15
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040085,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-10-20
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040085,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-10-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040085,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-11-01
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040086,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-10-13
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040086,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2017-10-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040086,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-10-30
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040086,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-11-02
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040087,Normal Issue,"
Received",2017-09-21
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040087,Normal Issue, Revised,2017-10-29
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040087,Normal Issue, Accepted,2017-10-31
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040087,Normal Issue, Published,2017-11-20
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040088,Normal Issue,"
Received",2017-09-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040088,Normal Issue, Revised,2017-10-30
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040088,Normal Issue, Accepted,2017-11-07
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040088,Normal Issue, Published,2017-11-09
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040089,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2017-09-22
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040089,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2017-11-02
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040089,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2017-11-13
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040089,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2017-11-16
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040091,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2017-10-24
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040091,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2017-11-14
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040091,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2017-11-18
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040091,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2017-11-21
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040093,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-10-31
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040093,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2017-11-14
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040093,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2017-11-19
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040093,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2017-11-28
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040094,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-11-25
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040094,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2017-11-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040094,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2017-12-04
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040095,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2017-11-13
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040095,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2017-12-05
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040095,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2017-12-05
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040095,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2017-12-09
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040096,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-10-01
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040096,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2017-11-27
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040096,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2017-11-29
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040096,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2017-12-12
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040097,Normal Issue,"
Received",2017-12-06
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040097,Normal Issue, Revised,2017-12-06
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040097,Normal Issue, Accepted,2017-12-06
Pharmaceuticals,2017,10,4,https://doi.org/10.3390/ph10040097,Normal Issue, Published,2017-12-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010001,Normal Issue,"
Received",2017-12-15
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010001,Normal Issue, Revised,2017-12-15
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010001,Normal Issue, Accepted,2017-12-15
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010001,Normal Issue, Published,2017-12-21
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010002,Normal Issue,"
Received",2017-10-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010002,Normal Issue, Revised,2017-11-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010002,Normal Issue, Accepted,2017-11-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010002,Normal Issue, Published,2017-12-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010003,Normal Issue,"
Received",2017-11-13
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010003,Normal Issue, Revised,2017-12-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010003,Normal Issue, Accepted,2017-12-27
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010003,Normal Issue, Published,2018-01-02
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010004,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)","
Received",2017-12-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010004,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Revised,2018-01-01
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010004,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Accepted,2018-01-04
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010004,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Published,2018-01-05
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010005,Normal Issue,"
Received",2018-01-09
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010005,Normal Issue, Revised,2018-01-09
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010005,Normal Issue, Accepted,2018-01-09
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010005,Normal Issue, Published,2018-01-10
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010006,Normal Issue,"
Received",2017-10-11
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010006,Normal Issue, Revised,2017-11-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010006,Normal Issue, Accepted,2017-11-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010006,Normal Issue, Published,2018-01-20
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010007,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)","
Received",2017-11-29
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010007,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Revised,2018-01-11
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010007,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Accepted,2018-01-18
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010007,"
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)", Published,2018-01-20
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010008,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2017-12-28
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010008,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2018-01-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010008,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2018-01-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010008,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2018-01-20
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010009,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)","
Received",2017-10-28
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010009,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Revised,2018-01-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010009,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Accepted,2018-01-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010009,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Published,2018-01-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010010,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-12-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010010,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-01-24
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010010,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-01-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010010,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-01-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010011,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-12-29
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010011,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2018-01-24
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010011,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2018-01-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010011,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2018-01-29
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010012,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-12-27
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010012,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2018-01-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010012,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2018-01-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010012,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2018-01-29
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010013,"
(This article belongs to the Special Issue Cannabinoids as Medicines)","
Received",2017-12-04
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010013,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Revised,2018-01-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010013,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Accepted,2018-01-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010013,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Published,2018-01-31
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010014,"
(This article belongs to the Special Issue Bacterial Drug Persisters: Basis, Regulatory Events, and Role in Pathogenesis)","
Received",2017-12-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010014,"
(This article belongs to the Special Issue Bacterial Drug Persisters: Basis, Regulatory Events, and Role in Pathogenesis)", Revised,2018-01-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010014,"
(This article belongs to the Special Issue Bacterial Drug Persisters: Basis, Regulatory Events, and Role in Pathogenesis)", Accepted,2018-01-27
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010014,"
(This article belongs to the Special Issue Bacterial Drug Persisters: Basis, Regulatory Events, and Role in Pathogenesis)", Published,2018-02-01
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010015,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2017-10-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010015,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-01-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010015,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-01-31
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010015,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-02-05
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010016,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2017-12-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010016,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-01-30
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010016,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-01-30
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010016,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-02-06
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010017,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2017-11-24
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010017,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2018-02-01
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010017,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2018-02-06
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010017,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010018,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-02-06
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010018,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010018,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010018,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-02-09
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010019,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-01-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010019,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010019,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010019,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-02-10
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010020,Normal Issue,"
Received",2017-12-13
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010020,Normal Issue, Revised,2018-02-08
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010020,Normal Issue, Accepted,2018-02-09
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010020,Normal Issue, Published,2018-02-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010021,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2018-01-21
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010021,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2018-02-07
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010021,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2018-02-13
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010021,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2018-02-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010022,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2018-01-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010022,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-02-01
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010022,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-02-13
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010022,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-02-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010023,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2017-11-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010023,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-02-13
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010023,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-02-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010023,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-02-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010024,Normal Issue,"
Received",2017-12-25
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010024,Normal Issue, Revised,2018-02-10
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010024,Normal Issue, Accepted,2018-02-12
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010024,Normal Issue, Published,2018-02-20
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010025,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-01-04
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010025,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-02-17
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010025,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-02-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010025,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-02-24
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010026,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2017-12-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010026,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-02-12
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010026,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-02-23
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010026,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-02-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010027,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)","
Received",2018-02-19
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010027,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Revised,2018-02-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010027,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Accepted,2018-02-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010027,"
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)", Published,2018-02-27
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010028,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-01-29
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010028,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-03-02
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010028,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-03-05
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010028,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-03-08
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010029,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2017-12-27
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010029,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2018-03-06
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010029,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2018-03-08
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010029,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2018-03-16
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010030,Normal Issue,"
Received",2018-01-26
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010030,Normal Issue, Revised,2018-03-12
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010030,Normal Issue, Accepted,2018-03-14
Pharmaceuticals,2018,11,1,https://doi.org/10.3390/ph11010030,Normal Issue, Published,2018-03-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020031,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-01-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020031,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-03-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020031,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-03-27
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020031,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-04-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020032,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-02-15
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020032,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2018-04-02
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020032,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2018-04-03
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020032,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2018-04-09
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020033,Normal Issue,"
Received",2018-03-21
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020033,Normal Issue, Revised,2018-04-13
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020033,Normal Issue, Accepted,2018-04-16
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020033,Normal Issue, Published,2018-04-19
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020034,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-03-20
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020034,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-04-11
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020034,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-04-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020034,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-04-19
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020035,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-03-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020035,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-04-10
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020035,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-04-10
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020035,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-04-21
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020036,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-03-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020036,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-04-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020036,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-04-18
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020036,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-04-23
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020037,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-04-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020037,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2018-04-23
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020037,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2018-04-25
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020037,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2018-04-29
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020038,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2018-04-03
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020038,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-04-24
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020038,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-04-24
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020038,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-04-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020039,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-03-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020039,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-04-15
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020039,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-05-02
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020039,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-05-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020040,Normal Issue,"
Received",2018-04-16
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020040,Normal Issue, Revised,2018-05-02
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020040,Normal Issue, Accepted,2018-05-03
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020040,Normal Issue, Published,2018-05-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020041,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2018-03-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020041,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-04-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020041,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-04-29
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020041,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-05-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020042,Normal Issue,"
Received",2018-04-09
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020042,Normal Issue, Revised,2018-04-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020042,Normal Issue, Accepted,2018-05-03
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020042,Normal Issue, Published,2018-05-07
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020043,Normal Issue,"
Received",2018-03-27
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020043,Normal Issue, Revised,2018-05-07
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020043,Normal Issue, Accepted,2018-05-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020043,Normal Issue, Published,2018-05-09
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020044,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2018-04-27
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020044,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-05-07
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020044,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-05-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020044,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-05-11
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020045,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-03-15
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020045,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-04-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020045,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-05-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020045,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-05-14
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020046,Normal Issue,"
Received",2018-04-16
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020046,Normal Issue, Revised,2018-05-03
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020046,Normal Issue, Accepted,2018-05-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020046,Normal Issue, Published,2018-05-14
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020047,Normal Issue,"
Received",2018-02-16
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020047,Normal Issue, Revised,2018-04-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020047,Normal Issue, Accepted,2018-04-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020047,Normal Issue, Published,2018-05-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020048,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)","
Received",2018-04-20
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020048,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Revised,2018-05-15
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020048,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Accepted,2018-05-16
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020048,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Published,2018-05-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020049,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-04-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020049,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-05-15
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020049,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-05-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020049,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-05-21
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020050,"
(This article belongs to the Special Issue Cannabinoids as Medicines)","
Received",2018-04-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020050,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Revised,2018-05-13
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020050,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Accepted,2018-05-18
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020050,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Published,2018-05-22
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020051,Normal Issue,"
Received",2018-03-26
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020051,Normal Issue, Revised,2018-05-21
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020051,Normal Issue, Accepted,2018-05-21
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020051,Normal Issue, Published,2018-05-25
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020052,Normal Issue,"
Received",2018-05-14
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020052,Normal Issue, Revised,2018-05-22
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020052,Normal Issue, Accepted,2018-05-23
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020052,Normal Issue, Published,2018-05-27
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020053,"
(This article belongs to the Special Issue New Advances in Pharmacological Targets for Pain)","
Received",2018-05-11
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020053,"
(This article belongs to the Special Issue New Advances in Pharmacological Targets for Pain)", Revised,2018-05-22
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020053,"
(This article belongs to the Special Issue New Advances in Pharmacological Targets for Pain)", Accepted,2018-05-23
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020053,"
(This article belongs to the Special Issue New Advances in Pharmacological Targets for Pain)", Published,2018-05-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020054,Normal Issue,"
Received",2018-05-08
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020054,Normal Issue, Revised,2018-05-23
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020054,Normal Issue, Accepted,2018-05-25
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020054,Normal Issue, Published,2018-05-29
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020055,"
(This article belongs to the Special Issue Cannabinoids as Medicines)","
Received",2018-04-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020055,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Revised,2018-05-17
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020055,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Accepted,2018-05-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020055,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Published,2018-05-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020056,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2018-05-02
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020056,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2018-05-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020056,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2018-06-01
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020056,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2018-06-04
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020057,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2018-04-30
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020057,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-06-01
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020057,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-06-02
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020057,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-06-05
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020058,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)","
Received",2018-04-25
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020058,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Revised,2018-05-28
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020058,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Accepted,2018-06-01
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020058,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Published,2018-06-07
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020059,"
(This article belongs to the Special Issue Heterocyclic Chemistry for Cancer and CNS Diseases)","
Received",2018-05-09
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020059,"
(This article belongs to the Special Issue Heterocyclic Chemistry for Cancer and CNS Diseases)", Revised,2018-05-22
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020059,"
(This article belongs to the Special Issue Heterocyclic Chemistry for Cancer and CNS Diseases)", Accepted,2018-05-25
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020059,"
(This article belongs to the Special Issue Heterocyclic Chemistry for Cancer and CNS Diseases)", Published,2018-06-11
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020060,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-04-12
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020060,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2018-06-07
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020060,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2018-06-11
Pharmaceuticals,2018,11,2,https://doi.org/10.3390/ph11020060,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2018-06-20
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030061,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2018-04-30
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030061,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2018-06-15
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030061,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2018-06-19
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030061,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2018-06-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030062,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-05-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030062,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-06-19
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030062,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-06-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030062,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-06-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030063,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2018-05-26
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030063,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2018-06-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030063,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2018-06-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030063,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2018-06-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030064,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2018-05-31
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030064,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2018-06-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030064,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2018-06-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030064,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2018-06-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030065,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-06-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030065,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-06-29
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030065,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-07-03
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030065,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-07-04
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030066,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2018-06-11
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030066,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2018-06-29
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030066,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2018-07-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030066,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2018-07-05
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030067,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-05-17
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030067,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-07-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030067,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-07-04
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030067,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-07-10
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030068,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2018-05-29
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030068,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-07-06
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030068,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-07-07
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030068,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-07-10
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030069,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-06-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030069,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-07-01
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030069,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-07-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030069,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-07-13
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030070,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-06-15
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030070,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-07-11
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030070,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-07-12
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030070,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-07-16
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030071,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-06-27
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030071,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-07-13
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030071,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-07-17
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030071,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-07-19
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030072,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2018-05-06
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030072,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2018-07-09
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030072,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2018-07-12
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030072,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2018-07-20
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030073,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-06-19
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030073,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-07-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030073,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-07-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030073,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-07-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030074,Normal Issue,"
Received",2018-05-31
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030074,Normal Issue, Revised,2018-07-06
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030074,Normal Issue, Accepted,2018-07-08
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030074,Normal Issue, Published,2018-07-26
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030075,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)","
Received",2018-06-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030075,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Revised,2018-07-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030075,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Accepted,2018-07-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030075,"
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)", Published,2018-07-26
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030076,Normal Issue,"
Received",2018-07-13
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030076,Normal Issue, Accepted,2018-07-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030076,Normal Issue, Published,2018-07-30
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030077,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-04-30
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030077,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-08-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030077,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-08-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030077,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-08-06
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030078,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)","
Received",2018-07-09
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030078,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Revised,2018-08-09
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030078,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Accepted,2018-08-11
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030078,"
(This article belongs to the Special Issue Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry)", Published,2018-08-14
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030079,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-08-01
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030079,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-08-21
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030079,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-08-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030079,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-08-24
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030080,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-07-29
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030080,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-08-20
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030080,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-08-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030080,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-08-26
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030081,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2018-07-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030081,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-08-17
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030081,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-08-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030081,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-08-27
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030082,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-01
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030082,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-08-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030082,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-08-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030082,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-08-27
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030083,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-07-24
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030083,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-08-23
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030083,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-08-25
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030083,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-08-29
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030084,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-06
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030084,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-08-27
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030084,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-08-28
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030084,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-09-01
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030085,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-13
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030085,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-04
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030085,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-09-07
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030085,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-09-10
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030086,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-07-24
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030086,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-08-30
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030086,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-09-02
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030086,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-09-11
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030087,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-07-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030087,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-07
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030087,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-09-14
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030087,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-09-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030088,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2018-08-22
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030088,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-09-13
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030088,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-09-14
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030088,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-09-18
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030089,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-10
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030089,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-15
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030089,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-09-17
Pharmaceuticals,2018,11,3,https://doi.org/10.3390/ph11030089,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-09-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040090,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)","
Received",2018-08-09
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040090,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Revised,2018-09-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040090,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Accepted,2018-09-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040090,"
(This article belongs to the Special Issue Transient Receptor Potential Ion Channels as Targets in Anti-Cancer Therapies)", Published,2018-09-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040091,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-08-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040091,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-09-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040091,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-09-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040091,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-09-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040092,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-07-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040092,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-09-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040092,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-09-20
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040092,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-09-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040093,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-07-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040093,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-09-20
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040093,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-09-24
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040093,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-09-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-31
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-27
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-09-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-09-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040095,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)","
Received",2018-08-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040095,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Revised,2018-09-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040095,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Accepted,2018-09-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040095,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)", Published,2018-09-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040096,"

(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040096,"

(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040096,"

(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-09-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040096,"

(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040097,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040097,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040097,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-02
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040097,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-04
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040098,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040098,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040098,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-02
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040098,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040099,Normal Issue,"
Received",2018-08-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040099,Normal Issue, Revised,2018-10-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040099,Normal Issue, Accepted,2018-10-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040099,Normal Issue, Published,2018-10-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040100,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-09-04
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040100,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2018-09-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040100,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2018-10-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040100,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2018-10-06
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040101,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-09-04
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040101,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2018-10-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040101,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2018-10-09
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040101,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2018-10-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040102,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-09-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040102,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-10-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040102,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-10-09
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040102,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-10-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040103,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040103,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-09-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040103,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040103,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040104,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)","
Received",2018-09-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040104,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Revised,2018-10-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040104,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Accepted,2018-10-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040104,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Published,2018-10-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040105,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-09-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040105,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2018-10-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040105,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2018-10-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040105,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2018-10-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040106,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-08-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040106,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-10-06
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040106,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-10-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040106,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-10-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040107,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040107,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040107,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040107,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040108,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-08-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040108,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-10-04
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040108,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-10-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040108,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-10-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040109,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-06-25
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040109,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-07-31
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040109,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-08-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040109,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040110,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040110,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040110,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040110,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-20
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040111,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040111,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040111,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040111,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040112,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040112,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040112,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040112,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040113,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-31
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040113,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040113,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040113,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040114,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040114,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040114,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040114,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040115,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-09-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040115,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040115,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-10-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040115,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-10-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040116,Normal Issue,"
Received",2018-08-29
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040116,Normal Issue, Revised,2018-10-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040116,Normal Issue, Accepted,2018-10-24
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040116,Normal Issue, Published,2018-11-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040117,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-10-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040117,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2018-10-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040117,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2018-10-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040117,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2018-11-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040118,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-09-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040118,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-10-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040118,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-10-18
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040118,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-11-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040119,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2018-10-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040119,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2018-10-29
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040119,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2018-10-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040119,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2018-11-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-10-31
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-01
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040121,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)","
Received",2018-10-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040121,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Revised,2018-11-02
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040121,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Accepted,2018-11-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040121,"
(This article belongs to the Special Issue New Advances in the Treatment of Nonalcoholic Fatty Liver Disease)", Published,2018-11-08
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040122,Normal Issue,"
Received",2018-07-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040122,Normal Issue, Revised,2018-10-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040122,Normal Issue, Accepted,2018-11-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040122,Normal Issue, Published,2018-11-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040123,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-10-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040123,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-11-02
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040123,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-11-09
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040123,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-11-13
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040124,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-24
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040124,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-11-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040124,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040124,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-13
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040125,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-09-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040125,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2018-11-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040125,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2018-11-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040125,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2018-11-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040126,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2018-10-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040126,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2018-11-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040126,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2018-11-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040126,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2018-11-20
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040127,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-11-03
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040127,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-11-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040127,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040127,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040128,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-09
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040128,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-11-07
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040128,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040128,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-22
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-11-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040130,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2018-10-17
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040130,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2018-11-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040130,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2018-11-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040130,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2018-11-23
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040131,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-08-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040131,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-11-16
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040131,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-19
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040131,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-11-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040132,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-10-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040132,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-11-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040132,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-11-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040132,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-11-28
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040133,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-09-24
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040133,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-11-21
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040133,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-11-27
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040133,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-11-30
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040134,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)","
Received",2018-10-26
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040134,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Revised,2018-11-24
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040134,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Accepted,2018-11-29
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040134,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Published,2018-12-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040135,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-11-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040135,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-12-05
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040135,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-12-06
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040135,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-12-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040136,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-10-31
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040136,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-12-06
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040136,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-12-11
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040136,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2018-12-13
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040137,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-11-15
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040137,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-12-10
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040137,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-12-12
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040137,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2018-12-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040138,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-11-06
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040138,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-12-07
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040138,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-12-14
Pharmaceuticals,2018,11,4,https://doi.org/10.3390/ph11040138,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-12-16
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010001,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-11-22
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010001,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2018-12-12
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010001,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2018-12-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010001,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2018-12-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010002,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-11-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010002,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Revised,2018-11-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010002,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-12-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010002,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2018-12-24
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010003,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010003,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-12-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010003,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-12-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010003,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-01-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010004,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2018-11-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010004,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2018-12-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010004,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2018-12-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010004,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-01-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010005,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-11-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010005,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2018-12-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010005,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-12-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010005,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-01-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010006,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)","
Received",2018-12-26
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010006,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Accepted,2018-12-28
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010006,"
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)", Published,2019-01-02
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010007,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-27
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010007,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-12-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010007,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2018-12-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010007,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-01-03
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010008,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2018-12-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010008,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2019-01-02
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010008,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2019-01-04
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010008,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-01-07
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010009,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2018-11-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010009,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2018-12-24
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010009,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2018-12-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010009,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2019-01-08
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010010,Normal Issue,"
Published",2019-01-09
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010011,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2018-11-16
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010011,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2019-01-02
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010011,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2019-01-04
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010011,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010012,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010012,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-12-27
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010012,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010012,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-01-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010013,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010013,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2019-01-08
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010013,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010013,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-01-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010014,Normal Issue,"
Received",2018-11-21
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010014,Normal Issue, Revised,2018-12-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010014,Normal Issue, Accepted,2019-01-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010014,Normal Issue, Published,2019-01-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010015,"
(This article belongs to the Special Issue Nano Drug Carriers)","
Received",2018-12-22
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010015,"
(This article belongs to the Special Issue Nano Drug Carriers)", Revised,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010015,"
(This article belongs to the Special Issue Nano Drug Carriers)", Accepted,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010015,"
(This article belongs to the Special Issue Nano Drug Carriers)", Published,2019-01-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010016,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-12-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010016,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-01-03
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010016,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-01-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010016,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-01-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010017,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-12-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010017,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-01-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010017,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-01-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010017,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-01-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010018,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010018,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2018-12-21
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010018,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-01-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010018,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-01-24
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010019,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-10-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010019,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2018-11-27
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010019,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2018-12-07
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010019,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2019-01-24
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010020,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2018-12-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010020,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-01-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010020,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-01-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010020,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-01-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010021,Normal Issue,"
Received",2018-12-28
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010021,Normal Issue, Revised,2019-01-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010021,Normal Issue, Accepted,2019-01-22
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010021,Normal Issue, Published,2019-01-26
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010022,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-10-09
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010022,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2018-11-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010022,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-01-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010023,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2019-01-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010023,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2019-01-28
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010023,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2019-01-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010023,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2019-02-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010024,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2018-12-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010024,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2019-01-21
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010024,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2019-01-31
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010024,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2019-02-02
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010025,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-11-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010025,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2019-01-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010025,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-01-31
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010025,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-02-05
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010026,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2018-12-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010026,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2019-01-27
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010026,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2019-02-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010026,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2019-02-06
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010027,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-12-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010027,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-01-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010027,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-01-29
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010027,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-02-09
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010028,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-01-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010028,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-02-01
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010028,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-02-09
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010028,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-02-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010029,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)","
Received",2019-01-08
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010029,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Revised,2019-02-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010029,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Accepted,2019-02-12
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010029,"
(This article belongs to the Special Issue Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment)", Published,2019-02-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010030,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2018-12-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010030,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-01-30
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010030,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-02-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010030,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-02-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010031,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2018-12-03
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010031,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2019-02-04
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010031,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-02-12
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010031,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-02-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010032,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-01-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010032,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-02-05
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010032,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-02-11
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010032,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-02-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010033,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-12-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010033,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-02-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010033,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-02-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010033,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-02-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010034,Normal Issue,"
Received",2019-01-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010034,Normal Issue, Revised,2019-01-31
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010034,Normal Issue, Accepted,2019-02-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010034,Normal Issue, Published,2019-03-04
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2018-12-28
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2019-02-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2019-03-04
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2019-03-11
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010036,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)","
Received",2018-11-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010036,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Revised,2019-02-25
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010036,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Accepted,2019-02-27
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010036,"
(This article belongs to the Special Issue Chemoinformatics and Drug Design)", Published,2019-03-12
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010037,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-02-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010037,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-03-05
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010037,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-03-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010037,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-03-12
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010038,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)","
Received",2019-02-26
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010038,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Revised,2019-03-07
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010038,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Accepted,2019-03-10
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010038,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Published,2019-03-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010039,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-02-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010039,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-03-05
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010039,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-03-08
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010039,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-03-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010040,Normal Issue,"
Received",2019-03-05
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010040,Normal Issue, Revised,2019-03-14
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010040,Normal Issue, Accepted,2019-03-16
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010040,Normal Issue, Published,2019-03-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010041,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2019-02-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010041,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2019-03-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010041,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2019-03-15
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010041,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2019-03-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010042,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2019-02-26
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010042,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Revised,2019-03-16
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010042,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-03-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010042,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-03-20
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2019-02-06
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2019-03-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2019-03-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010043,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2019-03-22
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010044,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-02-22
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010044,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-03-17
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010044,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-03-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010044,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-03-23
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010045,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2019-02-18
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010045,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2019-03-13
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010045,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2019-03-19
Pharmaceuticals,2019,12,1,https://doi.org/10.3390/ph12010045,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2019-03-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020046,Normal Issue,"
Received",2019-02-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020046,Normal Issue, Revised,2019-03-23
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020046,Normal Issue, Accepted,2019-03-27
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020046,Normal Issue, Published,2019-03-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020047,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-02-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020047,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-03-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020047,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-03-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020047,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-03-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020048,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2019-03-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020048,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2019-03-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020048,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2019-03-27
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020048,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2019-03-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020049,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2019-02-27
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020049,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2019-03-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020049,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2019-03-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020049,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2019-04-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020050,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2019-02-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020050,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2019-03-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020050,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2019-03-28
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020050,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-04-02
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020051,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2018-12-31
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020051,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-02-27
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020051,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-03-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020051,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-04-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020052,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-03-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020052,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-04-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020052,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-04-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020052,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-04-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020053,Normal Issue,"
Received",2019-02-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020053,Normal Issue, Revised,2019-03-07
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020053,Normal Issue, Accepted,2019-03-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020053,Normal Issue, Published,2019-04-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020054,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)","
Received",2019-03-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020054,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Revised,2019-04-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020054,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Accepted,2019-04-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020054,"
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels in Drug Discovery: Unlocking the Potential)", Published,2019-04-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020055,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-03-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020055,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-04-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020055,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-04-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020055,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-04-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020056,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2019-03-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020056,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-04-02
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020056,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-04-07
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020056,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-04-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020057,Normal Issue,"
Received",2019-03-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020057,Normal Issue, Revised,2019-04-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020057,Normal Issue, Accepted,2019-04-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020057,Normal Issue, Published,2019-04-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020058,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)","
Received",2019-03-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020058,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Revised,2019-04-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020058,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Accepted,2019-04-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020058,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Published,2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020059,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-03-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020059,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-04-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020059,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-04-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020059,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020060,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)","
Received",2019-03-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020060,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Revised,2019-03-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020060,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Accepted,2019-03-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020060,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Published,2019-04-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020061,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-02-25
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020061,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-04-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020061,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-04-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020061,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-04-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020062,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-03-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020062,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020062,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-04-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020062,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-04-20
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020063,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-03-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020063,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020063,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-04-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020063,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-04-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020064,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-04-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020064,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-04-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020064,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-04-20
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020064,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-04-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020065,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2019-03-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020065,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2019-04-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020065,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2019-04-23
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020065,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2019-04-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020066,Normal Issue,"
Received",2019-04-02
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020066,Normal Issue, Revised,2019-04-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020066,Normal Issue, Accepted,2019-04-25
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020066,Normal Issue, Published,2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020067,Normal Issue,"
Received",2019-04-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020067,Normal Issue, Revised,2019-04-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020067,Normal Issue, Accepted,2019-05-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020067,Normal Issue, Published,2019-05-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020068,Normal Issue,"
Received",2019-03-22
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020068,Normal Issue, Revised,2019-04-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020068,Normal Issue, Accepted,2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020068,Normal Issue, Published,2019-05-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020069,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-04-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020069,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-05-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020069,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-05-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020069,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-05-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020070,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-02-25
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020070,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020070,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-05-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020070,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-05-07
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020071,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-02-28
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020071,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-05-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020071,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-05-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020071,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-05-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020072,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-04-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020072,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2019-05-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020072,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2019-05-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020072,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2019-05-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020073,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-05-07
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020073,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-05-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020073,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2019-05-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020074,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020074,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-05-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020074,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-05-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020074,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-05-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020075,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-04-28
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020075,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-05-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020075,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-05-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020075,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-05-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020076,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2019-04-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020076,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-05-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020076,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-05-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020076,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-05-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020077,"
(This article belongs to the Special Issue Matrix Metalloproteinases)","
Received",2019-05-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020077,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Revised,2019-05-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020077,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Accepted,2019-05-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020077,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Published,2019-05-20
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020078,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-04-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020078,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-05-16
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020078,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-05-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020078,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-05-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020079,"
(This article belongs to the Special Issue Matrix Metalloproteinases)","
Received",2019-05-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020079,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Revised,2019-05-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020079,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Accepted,2019-05-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020079,"
(This article belongs to the Special Issue Matrix Metalloproteinases)", Published,2019-05-22
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020080,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-04-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020080,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-04-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020080,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-05-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020080,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-05-23
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020081,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020081,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-05-20
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020081,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-05-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020081,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-05-28
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020082,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)","
Received",2019-04-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020082,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Revised,2019-05-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020082,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Accepted,2019-05-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020082,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Published,2019-06-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020083,"
(This article belongs to the Special Issue Advanced Electrochemical Sensors in Drug Sensing)","
Received",2019-04-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020083,"
(This article belongs to the Special Issue Advanced Electrochemical Sensors in Drug Sensing)", Revised,2019-05-02
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020083,"
(This article belongs to the Special Issue Advanced Electrochemical Sensors in Drug Sensing)", Accepted,2019-05-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020083,"
(This article belongs to the Special Issue Advanced Electrochemical Sensors in Drug Sensing)", Published,2019-06-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020084,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-05-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020084,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-05-24
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020084,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-05-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020084,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-06-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020085,Normal Issue,"
Received",2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020085,Normal Issue, Revised,2019-06-01
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020085,Normal Issue, Accepted,2019-06-03
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020085,Normal Issue, Published,2019-06-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020086,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-05-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020086,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-06-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020086,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-06-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020086,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-06-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020087,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-05-15
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020087,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-06-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020087,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-06-08
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020087,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-06-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020088,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2019-06-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020088,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-06-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020088,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-06-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020089,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2019-05-04
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020089,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2019-06-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020089,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2019-06-13
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020089,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020090,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2019-05-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020090,"
(This article belongs to the Special Issue Anticancer Drugs)", Revised,2019-06-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020090,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-06-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020090,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020091,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)","
Received",2019-05-29
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020091,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Revised,2019-06-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020091,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Accepted,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020091,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Published,2019-06-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020092,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2019-05-10
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020092,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2019-06-11
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020092,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2019-06-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020092,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020093,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-05-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020093,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020093,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-06-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020093,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-05-31
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-06-17
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020094,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020095,Normal Issue,"
Received",2019-05-25
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020095,Normal Issue, Revised,2019-06-12
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020095,Normal Issue, Accepted,2019-06-18
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020095,Normal Issue, Published,2019-06-20
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020096,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-04-30
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020096,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020096,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020096,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-06-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020097,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)","
Received",2019-05-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020097,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Revised,2019-06-14
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020097,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Accepted,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020097,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Published,2019-06-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020098,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-04-09
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020098,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-06-05
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020098,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-06-06
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020098,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-06-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020099,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-05-26
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020099,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-06-19
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020099,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-06-21
Pharmaceuticals,2019,12,2,https://doi.org/10.3390/ph12020099,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-06-24
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030100,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-06-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030100,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-06-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030100,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-06-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030100,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-06-28
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030101,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)","
Received",2019-05-31
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030101,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Revised,2019-06-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030101,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Accepted,2019-06-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030101,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Published,2019-06-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030102,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-05-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030102,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-06-21
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030102,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-06-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030102,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-07-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030103,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-05-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030103,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-06-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030103,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-06-27
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030103,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-07-02
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030104,"
(This article belongs to the Special Issue Cannabinoids as Medicines)","
Received",2019-05-24
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030104,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Revised,2019-06-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030104,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Accepted,2019-06-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030104,"
(This article belongs to the Special Issue Cannabinoids as Medicines)", Published,2019-07-04
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030105,Normal Issue,"
Received",2019-04-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030105,Normal Issue, Revised,2019-06-18
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030105,Normal Issue, Accepted,2019-06-24
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030105,Normal Issue, Published,2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030106,Normal Issue,"
Received",2019-05-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030106,Normal Issue, Revised,2019-06-28
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030106,Normal Issue, Accepted,2019-07-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030106,Normal Issue, Published,2019-07-11
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030107,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-05-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030107,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-06-21
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030107,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-06-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030107,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-07-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030108,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-06-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030108,"
(This article belongs to the Special Issue Carbohydrates 2018)", Revised,2019-07-08
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030108,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030108,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-07-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030109,Normal Issue,"
Received",2019-06-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030109,Normal Issue, Revised,2019-07-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030109,Normal Issue, Accepted,2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030109,Normal Issue, Published,2019-07-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030110,Normal Issue,"
Received",2019-06-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030110,Normal Issue, Revised,2019-07-08
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030110,Normal Issue, Accepted,2019-07-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030110,Normal Issue, Published,2019-07-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030111,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)","
Received",2019-07-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030111,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Accepted,2019-07-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030111,"
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)", Published,2019-07-18
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030112,Normal Issue,"
Received",2019-06-19
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030112,Normal Issue, Revised,2019-07-13
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030112,Normal Issue, Accepted,2019-07-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030112,Normal Issue, Published,2019-07-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030113,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-06-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030113,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030113,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-07-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030113,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-07-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030114,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-07-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030114,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-07-23
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030114,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-07-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030114,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-07-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030115,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-07-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030115,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-07-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030115,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-07-27
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030115,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-07-30
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030116,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)","
Received",2019-05-31
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030116,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Revised,2019-07-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030116,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Accepted,2019-07-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030116,"
(This article belongs to the Special Issue Molecular Dynamics in Drug Design)", Published,2019-08-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030117,Normal Issue,"
Received",2019-05-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030117,Normal Issue, Revised,2019-07-24
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030117,Normal Issue, Accepted,2019-07-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030117,Normal Issue, Published,2019-08-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030118,Normal Issue,"
Received",2019-05-14
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030118,Normal Issue, Revised,2019-07-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030118,Normal Issue, Accepted,2019-08-02
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030118,Normal Issue, Published,2019-08-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030119,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-06-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030119,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-07-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030119,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-05
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030119,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-08
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-13
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030120,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-14
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030121,Normal Issue,"
Received",2019-07-22
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030121,Normal Issue, Revised,2019-08-11
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030121,Normal Issue, Accepted,2019-08-13
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030121,Normal Issue, Published,2019-08-19
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030122,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030122,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-14
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030122,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030122,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-22
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030123,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030123,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-05
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030123,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-14
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030123,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-23
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030124,Normal Issue,"
Received",2019-07-25
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030124,Normal Issue, Revised,2019-08-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030124,Normal Issue, Accepted,2019-08-23
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030124,Normal Issue, Published,2019-08-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030125,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030125,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-19
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030125,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-22
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030125,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-28
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030126,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-08-05
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030126,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-26
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030126,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-27
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030126,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-08-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030127,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)","
Received",2019-07-03
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030127,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Revised,2019-08-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030127,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Accepted,2019-08-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030127,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Published,2019-08-30
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030128,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)","
Received",2019-07-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030128,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Revised,2019-08-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030128,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Accepted,2019-08-28
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030128,"
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)", Published,2019-08-31
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-18
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-28
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-29
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030129,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-09-02
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030130,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2019-07-05
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030130,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2019-08-24
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030130,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2019-09-01
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030130,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2019-09-07
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030131,Normal Issue,"
Received",2019-07-04
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030131,Normal Issue, Revised,2019-08-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030131,Normal Issue, Accepted,2019-09-03
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030131,Normal Issue, Published,2019-09-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030132,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030132,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-08-14
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030132,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-08-20
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030132,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-09-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030133,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-07-30
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030133,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-09-02
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030133,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-09-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030133,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-09-11
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030134,"
(This article belongs to the Special Issue Anticancer Drugs)","
Received",2019-09-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030134,"
(This article belongs to the Special Issue Anticancer Drugs)", Accepted,2019-09-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030134,"
(This article belongs to the Special Issue Anticancer Drugs)", Published,2019-09-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030135,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-07-02
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030135,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-08-06
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030135,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-08-15
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030135,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-09-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030136,Normal Issue,"
Received",2019-05-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030136,Normal Issue, Revised,2019-08-31
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030136,Normal Issue, Accepted,2019-09-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030136,Normal Issue, Published,2019-09-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030137,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-08-21
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030137,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2019-09-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030137,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2019-09-11
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030137,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2019-09-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030138,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-23
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030138,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-09-10
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030138,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-09-11
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030138,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-09-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030139,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)","
Received",2019-08-09
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030139,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Revised,2019-09-13
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030139,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Accepted,2019-09-16
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030139,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)", Published,2019-09-17
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030140,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-07-30
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030140,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-08-30
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030140,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-09-12
Pharmaceuticals,2019,12,3,https://doi.org/10.3390/ph12030140,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-09-18
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040141,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-08-16
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040141,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-09-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040141,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-09-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040141,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2019-09-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040142,Normal Issue,"
Received",2019-08-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040142,Normal Issue, Revised,2019-08-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040142,Normal Issue, Accepted,2019-09-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040142,Normal Issue, Published,2019-09-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040143,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-08-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040143,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-09-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040143,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-09-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040143,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-09-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040144,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-07-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040144,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-09-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040144,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-09-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040144,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-09-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040145,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-08-01
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040145,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-09-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040145,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-09-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040145,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-09-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040146,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-08-31
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040146,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2019-09-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040146,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2019-09-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040146,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2019-09-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040147,"
(This article belongs to the Special Issue Advances in Anti-Influenza Therapeutics)","
Received",2019-08-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040147,"
(This article belongs to the Special Issue Advances in Anti-Influenza Therapeutics)", Revised,2019-09-11
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040147,"
(This article belongs to the Special Issue Advances in Anti-Influenza Therapeutics)", Accepted,2019-09-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040147,"
(This article belongs to the Special Issue Advances in Anti-Influenza Therapeutics)", Published,2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040148,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-08-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040148,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-09-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040148,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040148,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-10-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040149,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-09-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040149,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-09-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040149,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-10-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040149,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-10-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040150,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2019-09-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040150,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2019-10-03
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040150,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2019-10-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040150,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2019-10-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040151,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-09-03
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040151,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-10-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040151,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-10-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040151,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-10-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040152,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2019-09-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040152,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2019-10-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040152,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2019-10-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040152,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2019-10-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040153,Normal Issue,"
Received",2019-08-29
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040153,Normal Issue, Revised,2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040153,Normal Issue, Accepted,2019-10-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040153,Normal Issue, Published,2019-10-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040154,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-09-13
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040154,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2019-10-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040154,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2019-10-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040154,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2019-10-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040155,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-09-18
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040155,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-10-11
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040155,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-10-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040155,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2019-10-15
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040156,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-10-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040156,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-10-15
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040156,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-10-16
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040157,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)","
Received",2019-09-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040157,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Revised,2019-10-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040157,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Accepted,2019-10-15
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040157,"
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)", Published,2019-10-16
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040158,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040158,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-10-15
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040158,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-10-18
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040158,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-10-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040159,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2019-09-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040159,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2019-10-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040159,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2019-10-18
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040159,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2019-10-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040160,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-09-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040160,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-10-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040160,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-10-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040160,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-10-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040161,Normal Issue,"
Received",2019-10-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040161,Normal Issue, Revised,2019-10-21
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040161,Normal Issue, Accepted,2019-10-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040161,Normal Issue, Published,2019-10-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040162,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)","
Received",2019-10-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040162,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Revised,2019-10-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040162,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Accepted,2019-10-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040162,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Published,2019-10-27
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040163,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040163,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2019-10-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040163,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2019-10-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040163,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2019-10-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040164,Normal Issue,"
Received",2019-10-03
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040164,Normal Issue, Revised,2019-10-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040164,Normal Issue, Accepted,2019-10-24
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040164,Normal Issue, Published,2019-11-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040165,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040165,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-10-29
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040165,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-11-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040165,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-11-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040166,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-10-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040166,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-11-02
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040166,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-11-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040166,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2019-11-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040167,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2019-10-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040167,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2019-11-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040167,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2019-11-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040167,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2019-11-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040168,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2019-09-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040168,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2019-11-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040168,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2019-11-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040168,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2019-11-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040169,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-10-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040169,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2019-11-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040169,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-11-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040169,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2019-11-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040170,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-10-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040170,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Revised,2019-11-15
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040170,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-11-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040170,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-11-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040171,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-10-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040171,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-11-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040171,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-11-21
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040171,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2019-11-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040172,Normal Issue,"
Received",2019-10-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040172,Normal Issue, Revised,2019-11-04
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040172,Normal Issue, Accepted,2019-11-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040172,Normal Issue, Published,2019-11-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040173,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-07-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040173,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040173,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-09-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040173,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-11-27
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040174,Normal Issue,"
Received",2019-11-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040174,Normal Issue, Revised,2019-11-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040174,Normal Issue, Accepted,2019-11-26
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040174,Normal Issue, Published,2019-11-27
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040175,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-10-01
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040175,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-11-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040175,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-11-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040175,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-11-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040176,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-10-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040176,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-11-22
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040176,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-11-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040176,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-12-02
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040177,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-10-25
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040177,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-11-29
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040177,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-11-29
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040177,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2019-12-03
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040178,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)","
Received",2019-11-27
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040178,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Accepted,2019-11-28
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040178,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)", Published,2019-12-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040179,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-11-30
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040179,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-12-02
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040179,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2019-12-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040180,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-11-20
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040180,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-12-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040180,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-12-06
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040180,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-12-08
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040181,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2019-10-19
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040181,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2019-12-05
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040181,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2019-12-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040181,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2019-12-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040182,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-11-29
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040182,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2019-12-09
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040182,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-12-10
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040182,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2019-12-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040183,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2019-11-07
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040183,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2019-12-11
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040183,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2019-12-12
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040183,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2019-12-16
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040184,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2019-10-23
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040184,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2019-12-11
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040184,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2019-12-13
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040184,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2019-12-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040185,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-10-18
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040185,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2019-12-13
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040185,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-12-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040185,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2019-12-17
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040186,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-12-03
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040186,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-12-13
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040186,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-12-14
Pharmaceuticals,2019,12,4,https://doi.org/10.3390/ph12040186,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-12-17
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010001,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)","
Received",2019-09-28
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010001,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Revised,2019-12-12
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010001,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Accepted,2019-12-23
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010001,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery)", Published,2019-12-24
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010002,Normal Issue,"
Received",2019-11-26
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010002,Normal Issue, Revised,2019-12-12
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010002,Normal Issue, Accepted,2019-12-19
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010002,Normal Issue, Published,2019-12-25
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010003,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-12-01
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010003,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2019-12-19
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010003,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2019-12-21
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010003,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2019-12-25
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010004,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-11-10
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010004,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2019-12-10
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010004,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2019-12-18
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010004,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2019-12-25
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010005,"
(This article belongs to the Special Issue Carbohydrates 2018)","
Received",2019-12-20
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010005,"
(This article belongs to the Special Issue Carbohydrates 2018)", Accepted,2019-12-20
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010005,"
(This article belongs to the Special Issue Carbohydrates 2018)", Published,2019-12-29
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010006,Normal Issue,"
Received",2019-12-30
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010006,Normal Issue, Accepted,2019-12-30
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010006,Normal Issue, Published,2020-01-01
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010007,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2019-12-04
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010007,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2019-12-18
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010007,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2019-12-20
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010007,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2020-01-02
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010008,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-11-29
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010008,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2019-12-20
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010008,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2019-12-23
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010008,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2020-01-03
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010009,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2019-12-23
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010009,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2020-01-02
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010009,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2020-01-04
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010009,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2020-01-07
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010010,Normal Issue,"
Received",2019-12-06
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010010,Normal Issue, Revised,2019-12-29
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010010,Normal Issue, Accepted,2020-01-04
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010010,Normal Issue, Published,2020-01-08
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010011,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-12-12
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010011,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2020-01-03
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010011,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2020-01-05
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010011,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2020-01-08
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010012,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-11-30
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010012,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2019-12-16
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010012,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2019-12-31
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010012,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2020-01-13
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010013,Normal Issue,"
Received",2019-12-21
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010013,Normal Issue, Revised,2020-01-09
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010013,Normal Issue, Accepted,2020-01-11
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010013,Normal Issue, Published,2020-01-13
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010014,Normal Issue,"
Published",2020-01-14
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010015,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2019-12-19
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010015,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2020-01-09
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010015,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2020-01-10
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010015,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2020-01-16
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010016,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)","
Received",2019-12-19
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010016,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Revised,2020-01-08
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010016,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-01-10
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010016,"
(This article belongs to the Special Issue Selected Papers from the 4th International Electronic Conference on Medicinal Chemistry)", Published,2020-01-17
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010017,Normal Issue,"
Received",2019-12-23
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010017,Normal Issue, Revised,2020-01-07
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010017,Normal Issue, Accepted,2020-01-09
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010017,Normal Issue, Published,2020-01-18
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010018,Normal Issue,"
Received",2019-12-19
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010018,Normal Issue, Revised,2020-01-09
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010018,Normal Issue, Accepted,2020-01-15
Pharmaceuticals,2020,13,1,https://doi.org/10.3390/ph13010018,Normal Issue, Published,2020-01-18
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020019,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2019-12-10
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020019,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2020-01-16
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020019,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2020-01-17
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020019,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2020-01-21
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020020,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2019-12-03
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020020,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2020-01-04
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020020,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2020-01-14
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020020,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2020-01-22
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020021,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-01-05
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020021,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-01-18
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020021,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-01-20
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020021,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-01-24
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020022,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2019-12-20
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020022,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2020-01-14
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020022,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2020-01-16
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020022,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2020-01-30
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020023,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2019-12-22
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020023,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2020-01-22
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020023,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2020-01-22
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020023,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2020-01-31
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020024,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2019-11-24
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020024,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2020-01-13
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020024,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2020-01-28
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020024,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2020-02-02
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020025,Normal Issue,"
Received",2019-12-24
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020025,Normal Issue, Revised,2020-01-16
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020025,Normal Issue, Accepted,2020-01-17
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020025,Normal Issue, Published,2020-02-03
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020026,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2020-01-01
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020026,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2020-01-26
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020026,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2020-01-30
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020026,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2020-02-05
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020027,"
(This article belongs to the Section Radiopharmaceutical Sciences)","
Received",2020-01-15
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020027,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Revised,2020-02-05
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020027,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Accepted,2020-02-10
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020027,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Published,2020-02-11
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020028,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2019-11-26
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020028,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2020-02-06
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020028,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2020-02-07
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020028,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2020-02-12
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020029,"
(This article belongs to the Section Pharmacology)","
Received",2019-12-04
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020029,"
(This article belongs to the Section Pharmacology)", Revised,2019-12-30
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020029,"
(This article belongs to the Section Pharmacology)", Accepted,2020-02-08
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020029,"
(This article belongs to the Section Pharmacology)", Published,2020-02-12
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020030,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-02-04
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020030,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-02-14
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020030,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-02-19
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020030,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-02-20
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020031,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2020-01-21
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020031,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2020-02-18
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020031,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2020-02-20
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020032,Normal Issue,"
Received",2019-12-31
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020032,Normal Issue, Revised,2020-02-02
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020032,Normal Issue, Accepted,2020-02-13
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020032,Normal Issue, Published,2020-02-20
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020033,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-01-15
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020033,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-02-17
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020033,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-02-19
Pharmaceuticals,2020,13,2,https://doi.org/10.3390/ph13020033,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-02-21
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030034,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-01-20
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030034,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-02-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030034,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-02-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030034,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-02-25
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)","
Received",2019-11-24
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Revised,2020-02-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Accepted,2020-02-24
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030035,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)", Published,2020-02-26
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030036,"
(This article belongs to the Special Issue Recent Effective Application of Bioisosterism)","
Received",2020-02-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030036,"
(This article belongs to the Special Issue Recent Effective Application of Bioisosterism)", Revised,2020-02-25
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030036,"
(This article belongs to the Special Issue Recent Effective Application of Bioisosterism)", Accepted,2020-02-26
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030036,"
(This article belongs to the Special Issue Recent Effective Application of Bioisosterism)", Published,2020-02-28
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030037,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-02-10
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030037,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-02-27
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030037,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-03-01
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030037,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-03-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030038,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2020-01-15
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030038,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2020-02-27
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030038,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2020-03-01
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030038,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2020-03-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030039,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2020-01-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030039,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2020-03-01
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030039,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2020-03-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030039,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2020-03-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030040,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2020-02-11
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030040,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2020-03-02
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030040,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2020-03-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030040,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2020-03-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030041,Normal Issue,"
Received",2020-02-06
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030041,Normal Issue, Revised,2020-02-27
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030041,Normal Issue, Accepted,2020-03-03
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030041,Normal Issue, Published,2020-03-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030042,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2020-01-31
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030042,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2020-02-27
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030042,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2020-03-01
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030042,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2020-03-06
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030043,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2020-01-16
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030043,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2020-02-12
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030043,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2020-02-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030043,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2020-03-10
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030044,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-02-25
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030044,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-03-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030044,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-03-07
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030044,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-03-11
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030045,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-02-27
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030045,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-03-11
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030045,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-03-11
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030045,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-03-14
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030046,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2019-12-28
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030046,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-02-22
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030046,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-02-29
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030046,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-03-16
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030047,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2020-02-28
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030047,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2020-03-12
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030047,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2020-03-15
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030047,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2020-03-17
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030048,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2020-02-22
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030048,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2020-03-14
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030048,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2020-03-16
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030048,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2020-03-18
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030049,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)","
Received",2020-02-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030049,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Revised,2020-03-13
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030049,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Accepted,2020-03-14
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030049,"
(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)", Published,2020-03-18
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030050,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-02-26
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030050,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-03-18
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030050,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-03-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030050,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-03-20
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030051,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-03-01
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030051,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-03-19
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030051,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-03-20
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030051,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-03-21
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030052,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-02-11
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030052,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-03-05
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030052,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-03-21
Pharmaceuticals,2020,13,3,https://doi.org/10.3390/ph13030052,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-03-24
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040053,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-02-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040053,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-03-21
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040053,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-03-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040053,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040054,Normal Issue,"
Received",2020-02-03
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040054,Normal Issue, Revised,2020-03-18
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040054,Normal Issue, Accepted,2020-03-24
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040054,Normal Issue, Published,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040055,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-02-27
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040055,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-03-21
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040055,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-03-22
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040055,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040056,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-02-28
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040056,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040056,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-03-27
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040056,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-03-29
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040057,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-02-19
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040057,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-03-16
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040057,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-03-27
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040057,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-03-29
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040058,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-03-08
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040058,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040058,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-03-27
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040058,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-03-29
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040059,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-02-28
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040059,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-03-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040059,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-03-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040059,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-03-30
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040060,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2020-03-16
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040060,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2020-03-27
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040060,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2020-03-29
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040060,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2020-04-01
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040061,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2020-03-09
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040061,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2020-03-30
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040061,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2020-04-01
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040061,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2020-04-03
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040062,Normal Issue,"
Received",2020-02-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040062,Normal Issue, Revised,2020-03-29
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040062,Normal Issue, Accepted,2020-04-01
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040062,Normal Issue, Published,2020-04-05
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040063,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-03-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040063,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-04-03
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040063,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-04-07
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040063,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-04-09
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040064,"
(This article belongs to the Section Natural Products)","
Received",2020-03-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040064,"
(This article belongs to the Section Natural Products)", Revised,2020-04-03
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040064,"
(This article belongs to the Section Natural Products)", Accepted,2020-04-04
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040064,"
(This article belongs to the Section Natural Products)", Published,2020-04-09
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040065,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-04-04
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040065,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-04-08
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040065,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-04-09
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040065,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-04-10
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040066,"
(This article belongs to the Collection New Tools for Medicinal Chemists)","
Received",2020-03-14
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040066,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Revised,2020-04-06
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040066,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Accepted,2020-04-07
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040066,"
(This article belongs to the Collection New Tools for Medicinal Chemists)", Published,2020-04-13
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040067,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-03-25
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040067,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-04-10
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040067,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-04-13
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040067,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-04-15
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040068,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-02-24
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040068,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-04-10
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040068,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-04-14
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040068,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-04-15
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040069,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-03-31
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040069,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-04-12
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040069,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-04-14
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040069,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-04-16
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040070,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-03-02
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040070,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-03-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040070,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-03-26
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040070,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-04-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040071,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-03-16
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040071,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-04-08
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040071,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-04-16
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040071,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-04-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040072,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2020-04-09
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040072,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2020-04-13
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040072,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2020-04-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040073,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-03-18
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040073,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-04-11
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040073,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-04-18
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040073,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-04-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040074,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-03-24
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040074,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-04-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040074,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-04-19
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040074,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-04-21
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040075,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-03-03
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040075,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-04-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040075,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-04-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040075,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-04-22
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040076,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)","
Received",2020-03-20
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040076,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Revised,2020-04-17
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040076,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Accepted,2020-04-21
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040076,"
(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)", Published,2020-04-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040077,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-03-02
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040077,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-04-14
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040077,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-04-15
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040077,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-04-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040078,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-03-10
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040078,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-04-21
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040078,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-04-23
Pharmaceuticals,2020,13,4,https://doi.org/10.3390/ph13040078,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-04-24
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050079,"
(This article belongs to the Section Natural Products)","
Received",2020-04-10
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050079,"
(This article belongs to the Section Natural Products)", Revised,2020-04-21
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050079,"
(This article belongs to the Section Natural Products)", Accepted,2020-04-23
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050079,"
(This article belongs to the Section Natural Products)", Published,2020-04-25
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050080,"
(This article belongs to the Section Pharmacology)","
Received",2020-03-24
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050080,"
(This article belongs to the Section Pharmacology)", Revised,2020-04-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050080,"
(This article belongs to the Section Pharmacology)", Accepted,2020-04-24
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050080,"
(This article belongs to the Section Pharmacology)", Published,2020-04-26
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050081,"
(This article belongs to the Section Pharmacology)","
Received",2020-02-19
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050081,"
(This article belongs to the Section Pharmacology)", Revised,2020-04-21
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050081,"
(This article belongs to the Section Pharmacology)", Accepted,2020-04-26
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050081,"
(This article belongs to the Section Pharmacology)", Published,2020-04-28
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050082,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-03-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050082,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-04-23
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050082,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-04-24
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050082,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-04-28
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050083,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2020-04-12
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050083,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2020-04-26
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050083,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2020-04-27
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050083,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2020-04-29
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050084,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-04-07
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050084,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-04-16
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050084,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-04-27
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050084,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-04-29
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050085,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-04-16
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050085,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2020-04-26
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050085,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2020-04-28
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050085,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2020-04-30
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050086,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-03-27
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050086,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-04-19
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050086,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-04-27
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050086,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-04-30
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050087,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-03-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050087,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-04-28
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050087,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-04-29
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050087,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-05-03
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050088,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-04-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050088,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-04-29
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050088,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-05-04
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050088,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050089,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2020-04-10
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050089,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2020-05-01
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050089,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050089,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2020-05-09
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050090,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-04-16
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050090,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-04-30
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050090,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-05-05
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050090,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-05-10
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050091,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-03-31
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050091,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-04-28
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050091,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050091,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-05-11
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050092,"
(This article belongs to the Section Pharmacology)","
Received",2020-04-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050092,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-09
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050092,"
(This article belongs to the Section Pharmacology)", Accepted,2020-05-10
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050092,"
(This article belongs to the Section Pharmacology)", Published,2020-05-12
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050093,"
(This article belongs to the Section Pharmacology)","
Received",2020-04-20
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050093,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-09
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050093,"
(This article belongs to the Section Pharmacology)", Accepted,2020-05-10
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050093,"
(This article belongs to the Section Pharmacology)", Published,2020-05-12
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050094,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-03-31
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050094,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-04-29
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050094,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-05-04
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050094,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-05-13
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050095,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-04-15
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050095,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050095,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-05-11
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050095,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-05-13
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050096,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-04-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050096,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-05-09
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050096,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-05-11
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050096,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-05-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050097,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-04-23
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050097,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-05-06
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050097,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-05-12
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050097,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-05-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050098,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-05-05
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050098,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-05-12
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050098,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-05-13
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050098,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-05-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050099,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-04-17
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050099,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-04-26
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050099,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050099,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-05-18
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050100,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-04-18
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050100,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-05-08
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050100,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-05-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050100,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-05-18
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050101,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)","
Received",2020-05-02
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050101,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Revised,2020-05-14
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050101,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Accepted,2020-05-19
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050101,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Published,2020-05-21
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050102,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-04-16
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050102,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-05-11
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050102,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-05-20
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050102,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-05-21
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050103,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-04-17
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050103,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-05-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050103,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-05-22
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050103,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-05-23
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050104,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)","
Received",2020-05-09
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050104,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Revised,2020-05-21
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050104,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Accepted,2020-05-23
Pharmaceuticals,2020,13,5,https://doi.org/10.3390/ph13050104,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Published,2020-05-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060105,Normal Issue,"
Received",2020-04-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060105,Normal Issue, Revised,2020-05-21
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060105,Normal Issue, Accepted,2020-05-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060105,Normal Issue, Published,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060106,"
(This article belongs to the Section Pharmacology)","
Received",2020-05-08
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060106,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060106,"
(This article belongs to the Section Pharmacology)", Accepted,2020-05-23
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060106,"
(This article belongs to the Section Pharmacology)", Published,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060107,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-04-20
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060107,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-05-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060107,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-05-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060107,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-05-27
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060108,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-04-30
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060108,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-05-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060108,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-05-24
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060108,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-05-28
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060109,"
(This article belongs to the Section Pharmacology)","
Received",2020-04-24
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060109,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-20
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060109,"
(This article belongs to the Section Pharmacology)", Accepted,2020-05-27
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060109,"
(This article belongs to the Section Pharmacology)", Published,2020-05-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060110,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)","
Received",2020-04-23
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060110,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Revised,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060110,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Accepted,2020-05-27
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060110,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Published,2020-05-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060111,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-04-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060111,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-05-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060111,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060111,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-05-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060112,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-04-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060112,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060112,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-05-27
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060112,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060113,"
(This article belongs to the Section Pharmacology)","
Received",2020-05-09
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060113,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060113,"
(This article belongs to the Section Pharmacology)", Accepted,2020-05-30
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060113,"
(This article belongs to the Section Pharmacology)", Published,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060114,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-04-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060114,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-05-19
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060114,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-05-27
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060114,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-06-02
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060115,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-05-10
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060115,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060115,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060115,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-06-03
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060116,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2020-04-29
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060116,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2020-05-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060116,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2020-05-30
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060116,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2020-06-04
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060117,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-05-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060117,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-05-23
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060117,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-06-03
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060117,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-06-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060118,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-05-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060118,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-05-30
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060118,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060118,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-06-09
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060119,"
(This article belongs to the Section Pharmacology)","
Received",2020-04-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060119,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060119,"
(This article belongs to the Section Pharmacology)", Accepted,2020-06-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060119,"
(This article belongs to the Section Pharmacology)", Published,2020-06-10
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060120,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-05-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060120,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-06-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060120,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-06-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060120,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-06-10
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060121,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-05-19
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060121,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-06-07
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060121,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-06-09
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060121,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-06-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060122,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-05-15
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060122,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-06-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060122,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-06-05
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060122,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-06-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060123,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-05-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060123,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-06-12
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060123,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-06-13
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060123,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-06-16
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060124,"
(This article belongs to the Section Pharmacology)","
Received",2020-05-12
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060124,"
(This article belongs to the Section Pharmacology)", Revised,2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060124,"
(This article belongs to the Section Pharmacology)", Accepted,2020-06-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060124,"
(This article belongs to the Section Pharmacology)", Published,2020-06-16
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060125,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-05-30
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060125,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-06-17
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060125,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-06-17
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060125,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2020-06-20
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060126,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-05-21
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060126,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-06-16
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060126,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-06-20
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060126,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-06-21
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060127,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-05-17
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060127,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-06-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060127,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-06-17
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060127,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-06-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060128,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)","
Received",2020-06-08
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060128,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Revised,2020-06-19
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060128,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Accepted,2020-06-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060128,"
(This article belongs to the Special Issue Targeted Protein Degradation: From Chemical Biology to Drug Discovery)", Published,2020-06-23
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060129,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)","
Received",2020-05-04
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060129,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Revised,2020-06-14
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060129,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Accepted,2020-06-19
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060129,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Published,2020-06-23
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060130,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-05-01
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060130,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-06-08
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060130,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-06-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060130,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-06-24
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060131,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-04-28
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060131,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-06-12
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060131,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-06-15
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060131,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-06-24
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060132,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-05-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060132,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-06-21
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060132,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-06-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060132,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-06-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060133,"
(This article belongs to the Section Natural Products)","
Received",2020-05-08
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060133,"
(This article belongs to the Section Natural Products)", Revised,2020-05-20
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060133,"
(This article belongs to the Section Natural Products)", Accepted,2020-05-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060133,"
(This article belongs to the Section Natural Products)", Published,2020-06-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060134,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-02
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060134,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-06-22
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060134,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-06-24
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060134,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-06-26
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060135,Normal Issue,"
Received",2020-05-28
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060135,Normal Issue, Revised,2020-06-11
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060135,Normal Issue, Accepted,2020-06-25
Pharmaceuticals,2020,13,6,https://doi.org/10.3390/ph13060135,Normal Issue, Published,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070136,"
(This article belongs to the Section Pharmacology)","
Received",2020-06-08
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070136,"
(This article belongs to the Section Pharmacology)", Revised,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070136,"
(This article belongs to the Section Pharmacology)", Accepted,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070136,"
(This article belongs to the Section Pharmacology)", Published,2020-06-27
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070137,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)","
Received",2020-05-21
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070137,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Revised,2020-06-25
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070137,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Accepted,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070137,"
(This article belongs to the Special Issue Photodynamic Therapy 2019)", Published,2020-06-28
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070138,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-06-08
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070138,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070138,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070138,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-06-29
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070139,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)","
Received",2020-05-21
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070139,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Revised,2020-06-25
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070139,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Accepted,2020-06-26
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070139,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Published,2020-06-29
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070140,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-04-22
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070140,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-06-19
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070140,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-06-28
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070140,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-06-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070141,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-05-31
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070141,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-06-23
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070141,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-06-25
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070141,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-06-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070142,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-05-28
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070142,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-06-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070142,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-07-01
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070142,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-07-06
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070143,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-05-29
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070143,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-06-24
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070143,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-07-03
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070143,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-07-06
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070144,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-01
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070144,"
(This article belongs to the Section Pharmacology)", Revised,2020-07-03
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070144,"
(This article belongs to the Section Pharmacology)", Accepted,2020-07-06
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070144,"
(This article belongs to the Section Pharmacology)", Published,2020-07-07
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070145,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-05-01
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070145,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-06-28
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070145,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-06-29
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070145,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-07-07
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070146,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-06-05
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070146,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-07-02
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070146,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-07-07
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070146,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-07-09
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070147,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-19
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070147,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-02
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070147,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-06
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070147,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-10
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070148,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-05-22
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070148,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-06-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070148,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-07-07
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070148,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-07-10
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070149,"
(This article belongs to the Section Pharmacology)","
Received",2020-06-15
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070149,"
(This article belongs to the Section Pharmacology)", Revised,2020-07-07
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070149,"
(This article belongs to the Section Pharmacology)", Accepted,2020-07-08
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070149,"
(This article belongs to the Section Pharmacology)", Published,2020-07-10
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070150,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-05-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070150,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-06-25
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070150,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-07-08
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070150,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-07-12
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070151,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)","
Received",2020-06-04
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070151,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Revised,2020-07-01
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070151,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Accepted,2020-07-09
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070151,"
(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)", Published,2020-07-13
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070152,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-06-30
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070152,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-07-12
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070152,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-07-13
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070152,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-07-15
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070153,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-05-31
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070153,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-07-10
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070153,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-07-14
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070153,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-07-16
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070154,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-07-02
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070154,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-07-13
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070154,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-07-15
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070154,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-07-17
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070155,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-06-29
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070155,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-07-15
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070155,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-07-16
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070155,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-07-18
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070156,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-06-05
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070156,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2020-07-01
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070156,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2020-07-14
Pharmaceuticals,2020,13,7,https://doi.org/10.3390/ph13070156,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2020-07-19
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080157,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)","
Received",2020-06-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080157,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Revised,2020-07-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080157,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Accepted,2020-07-20
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080157,"
(This article belongs to the Special Issue Selected Papers from the 5th International Electronic Conference on Medicinal Chemistry)", Published,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080158,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080158,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-18
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080158,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-20
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080158,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080159,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-06-18
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080159,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-07-16
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080159,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080159,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080160,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080160,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080160,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-20
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080160,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080161,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2020-06-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080161,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2020-07-20
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080161,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080161,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2020-07-24
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080162,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-18
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080162,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080162,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080162,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-24
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080163,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-06-10
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080163,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-06-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080163,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080163,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-07-24
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080164,"
(This article belongs to the Special Issue Aging and Drug Discovery)","
Received",2020-06-26
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080164,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Revised,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080164,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Accepted,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080164,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Published,2020-07-25
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080165,"
(This article belongs to the Special Issue Choices of the Journal)","
Received",2020-06-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080165,"
(This article belongs to the Special Issue Choices of the Journal)", Revised,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080165,"
(This article belongs to the Special Issue Choices of the Journal)", Accepted,2020-07-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080165,"
(This article belongs to the Special Issue Choices of the Journal)", Published,2020-07-25
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080166,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-07-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080166,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080166,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-07-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080166,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-07-26
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080167,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080167,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080167,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-21
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080167,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-27
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080168,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-07-08
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080168,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-07-24
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080168,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080169,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)","
Received",2020-06-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080169,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Revised,2020-07-25
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080169,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Accepted,2020-07-26
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080169,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Published,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080170,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)","
Received",2020-07-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080170,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Revised,2020-07-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080170,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Accepted,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080170,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Published,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080171,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-07-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080171,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-07-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080171,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080171,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080172,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)","
Received",2020-06-18
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080172,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Revised,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080172,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Accepted,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080172,"
(This article belongs to the Special Issue Targeting the Eph–ephrin System)", Published,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080173,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))","
Received",2020-07-16
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080173,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Revised,2020-07-27
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080173,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Accepted,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080173,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Published,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080174,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-06-27
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080174,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-07-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080174,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080174,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080175,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-06-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080175,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-07-22
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080175,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080175,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-07-31
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080176,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080176,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080176,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080176,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-07-31
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080177,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2020-06-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080177,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080177,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080177,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2020-07-31
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080178,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)","
Received",2020-06-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080178,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Revised,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080178,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Accepted,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080178,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Published,2020-08-01
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080179,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-07-01
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080179,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080179,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2020-08-01
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080179,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2020-08-04
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080180,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-06-18
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080180,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-07-27
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080180,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-08-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080180,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-08-04
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080181,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)","
Received",2020-07-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080181,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)", Revised,2020-07-31
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080181,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)", Accepted,2020-08-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080181,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)", Published,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080182,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080182,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080182,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-07-31
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080182,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-08-06
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080183,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-07-14
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080183,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-08-02
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080183,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080183,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-08-06
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080184,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080184,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080184,"
(This article belongs to the Section Pharmacology)", Published,2020-08-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080185,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-07-06
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080185,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080185,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080185,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-08-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080186,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)","
Received",2020-07-15
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080186,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Revised,2020-07-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080186,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Accepted,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080186,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Published,2020-08-08
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080187,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-07-16
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080187,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080187,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-08-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080187,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-08-08
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080188,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-07-13
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080188,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080188,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-08-04
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080188,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-08-08
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080189,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080189,"
(This article belongs to the Section Pharmacology)", Revised,2020-08-05
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080189,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080189,"
(This article belongs to the Section Pharmacology)", Published,2020-08-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080190,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-06-29
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080190,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080190,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080190,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-08-11
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080191,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-07-08
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080191,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-07-30
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080191,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-08-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080191,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080192,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2020-06-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080192,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2020-08-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080192,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2020-08-10
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080192,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080193,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-07-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080193,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-08-06
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080193,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-08-07
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080193,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-08-13
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080194,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-07-03
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080194,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-10
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080194,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080194,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-14
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080195,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-28
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080195,"
(This article belongs to the Section Pharmacology)", Revised,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080195,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-14
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080195,"
(This article belongs to the Section Pharmacology)", Published,2020-08-15
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080196,"
(This article belongs to the Special Issue Antiparasitics)","
Received",2020-07-19
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080196,"
(This article belongs to the Special Issue Antiparasitics)", Revised,2020-08-09
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080196,"
(This article belongs to the Special Issue Antiparasitics)", Accepted,2020-08-13
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080196,"
(This article belongs to the Special Issue Antiparasitics)", Published,2020-08-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080197,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)","
Received",2020-08-04
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080197,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Revised,2020-08-10
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080197,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Accepted,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080197,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Published,2020-08-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080198,"
(This article belongs to the Section Natural Products)","
Received",2020-06-23
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080198,"
(This article belongs to the Section Natural Products)", Revised,2020-08-12
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080198,"
(This article belongs to the Section Natural Products)", Accepted,2020-08-13
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080198,"
(This article belongs to the Section Natural Products)", Published,2020-08-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080199,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-07-27
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080199,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-08-11
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080199,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-08-13
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080199,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-08-17
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080200,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-15
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080200,"
(This article belongs to the Section Pharmacology)", Revised,2020-08-14
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080200,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-16
Pharmaceuticals,2020,13,8,https://doi.org/10.3390/ph13080200,"
(This article belongs to the Section Pharmacology)", Published,2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090201,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-07-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090201,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-08-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090201,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090201,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090202,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)","
Received",2020-07-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090202,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Revised,2020-08-13
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090202,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Accepted,2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090202,"
(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)", Published,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090203,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-06-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090203,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090203,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090203,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-08-20
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090204,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)","
Received",2020-07-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090204,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Revised,2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090204,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Accepted,2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090204,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Published,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090205,"
(This article belongs to the Section Medicinal Chemistry)","
 Received",2020-07-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090205,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-08-13
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090205,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090205,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090206,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-07-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090206,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-08-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090206,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090206,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090207,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090207,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090207,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090207,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-08-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090208,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090208,"
(This article belongs to the Section Pharmacology)", Revised,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090208,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090208,"
(This article belongs to the Section Pharmacology)", Published,2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090209,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-07-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090209,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090209,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090209,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090210,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-08-12
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090210,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090210,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090210,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090211,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-05
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090211,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090211,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090211,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090212,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090212,"
(This article belongs to the Section Pharmacology)", Revised,2020-08-04
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090212,"
(This article belongs to the Section Pharmacology)", Accepted,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090212,"
(This article belongs to the Section Pharmacology)", Published,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090213,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-07-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090213,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090213,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090213,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090214,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)","
Received",2020-07-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090214,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Revised,2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090214,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Accepted,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090214,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Published,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090215,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-07-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090215,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-08-23
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090215,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090215,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090216,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-05
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090216,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090216,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090216,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090217,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090217,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090217,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090217,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090218,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-07-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090218,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090218,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090218,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090219,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)","
Received",2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090219,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090219,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Accepted,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090219,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090220,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-07-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090220,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090220,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090220,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090221,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)","
Received",2020-07-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090221,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Revised,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090221,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Accepted,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090221,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Published,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090222,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-08-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090222,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-08-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090222,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090223,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090223,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090223,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090223,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090224,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-08
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090224,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090224,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090224,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090225,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-07-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090225,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-08-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090225,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090225,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-08-30
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090226,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-07-30
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090226,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090226,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090226,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090227,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2020-08-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090227,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090227,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090227,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090228,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2020-08-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090228,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090228,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090228,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090229,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-07-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090229,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090229,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-08-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090229,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090230,"
(This article belongs to the Special Issue Cerebral Production and Action of Pro-inflammatory Cytokines)","
Received",2020-08-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090230,"
(This article belongs to the Special Issue Cerebral Production and Action of Pro-inflammatory Cytokines)", Revised,2020-08-27
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090230,"
(This article belongs to the Special Issue Cerebral Production and Action of Pro-inflammatory Cytokines)", Accepted,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090230,"
(This article belongs to the Special Issue Cerebral Production and Action of Pro-inflammatory Cytokines)", Published,2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090231,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090231,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090231,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090231,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090232,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-08-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090232,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090232,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090232,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-09-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090233,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-07-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090233,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-08-26
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090233,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090233,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-09-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090234,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-08-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090234,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090234,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090234,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-09-04
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090235,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2020-07-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090235,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090235,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2020-09-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090235,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2020-09-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090236,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)","
Received",2020-08-20
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090236,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Revised,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090236,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Accepted,2020-09-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090236,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Published,2020-09-08
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090237,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)","
Received",2020-08-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090237,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Revised,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090237,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Accepted,2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090237,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Published,2020-09-08
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090238,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090238,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090238,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-09-04
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090238,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-09-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090239,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090239,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-04
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090239,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-09-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090239,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-09-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090240,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090240,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-03
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090240,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090240,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090241,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2020-07-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090241,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2020-08-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090241,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2020-09-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090241,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2020-09-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090242,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-07-30
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090242,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-09-01
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090242,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-09-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090242,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-09-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090243,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-07-30
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090243,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-09-09
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090243,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-09-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090243,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-09-12
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090244,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-08-06
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090244,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-09-08
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090244,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-09-12
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090244,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090245,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)","
Received",2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090245,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Revised,2020-09-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090245,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Accepted,2020-09-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090245,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Published,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090246,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-07-28
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090246,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2020-09-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090246,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2020-09-12
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090246,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090247,"
(This article belongs to the Special Issue Aging and Drug Discovery)","
Received",2020-08-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090247,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Revised,2020-09-08
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090247,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Accepted,2020-09-10
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090247,"
(This article belongs to the Special Issue Aging and Drug Discovery)", Published,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090248,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)","
Received",2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090248,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Revised,2020-09-11
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090248,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Accepted,2020-09-13
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090248,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Published,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090249,"
(This article belongs to the Section Pharmacology)","
Received",2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090249,"
(This article belongs to the Section Pharmacology)", Revised,2020-09-06
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090249,"
(This article belongs to the Section Pharmacology)", Accepted,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090249,"
(This article belongs to the Section Pharmacology)", Published,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090250,"
(This article belongs to the Section Radiopharmaceutical Sciences)","
Received",2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090250,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Revised,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090250,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Accepted,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090250,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Published,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090251,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)","
Received",2020-08-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090251,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Revised,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090251,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Accepted,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090251,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Published,2020-09-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090252,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-07-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090252,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-05
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090252,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090252,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090253,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)","
Received",2020-08-25
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090253,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Revised,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090253,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Accepted,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090253,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Published,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090254,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)","
Received",2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090254,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Revised,2020-09-13
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090254,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Accepted,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090254,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Published,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090255,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-29
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090255,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090255,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090255,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090256,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-09-02
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090256,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090256,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-09-16
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090256,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-09-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090257,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)","
Received",2020-08-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090257,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Revised,2020-09-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090257,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Accepted,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090257,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Published,2020-09-20
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090258,Normal Issue,"
Received",2020-07-31
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090258,Normal Issue, Revised,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090258,Normal Issue, Accepted,2020-09-20
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090258,Normal Issue, Published,2020-09-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090259,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-08-20
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090259,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090259,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090259,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-09-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090260,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2020-07-24
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090260,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Revised,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090260,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090260,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2020-09-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090261,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2020-08-17
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090261,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2020-09-14
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090261,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2020-09-19
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090261,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2020-09-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090262,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-09-07
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090262,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-09-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090262,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-09-21
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090262,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-09-22
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090263,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-08-13
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090263,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-09-15
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090263,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-09-18
Pharmaceuticals,2020,13,9,https://doi.org/10.3390/ph13090263,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-09-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010001,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-11-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010001,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-12-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010001,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-12-19
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010001,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010002,"
(This article belongs to the Special Issue The Regulation of JAKs in Health and in Disease)","
Received",2020-11-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010002,"
(This article belongs to the Special Issue The Regulation of JAKs in Health and in Disease)", Revised,2020-12-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010002,"
(This article belongs to the Special Issue The Regulation of JAKs in Health and in Disease)", Accepted,2020-12-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010002,"
(This article belongs to the Special Issue The Regulation of JAKs in Health and in Disease)", Published,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010003,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-10-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010003,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2020-12-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010003,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2020-12-19
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010003,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010004,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010004,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010004,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010004,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010005,Normal Issue,"
Received",2020-11-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010005,Normal Issue, Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010005,Normal Issue, Accepted,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010005,Normal Issue, Published,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010006,Normal Issue,"
Received",2020-11-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010006,Normal Issue, Revised,2020-12-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010006,Normal Issue, Accepted,2020-12-19
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010006,Normal Issue, Published,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010007,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-11-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010007,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-11-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010007,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010008,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2020-11-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010008,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2020-11-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010008,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2020-11-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010008,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010009,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010009,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2020-12-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010009,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010009,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010010,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010010,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2020-12-16
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010010,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010010,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010011,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-11-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010011,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-12-19
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010011,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010011,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010012,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-11-04
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010012,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2020-12-19
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010012,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010012,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010013,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010013,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010013,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010013,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010014,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-12-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010014,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010014,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010014,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010015,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-11-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010015,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010015,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010015,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-12-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010016,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-11-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010016,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010016,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010016,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-12-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010017,"
(This article belongs to the Special Issue Epigenetic Drugs)","
Received",2020-11-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010017,"
(This article belongs to the Special Issue Epigenetic Drugs)", Revised,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010017,"
(This article belongs to the Special Issue Epigenetic Drugs)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010017,"
(This article belongs to the Special Issue Epigenetic Drugs)", Published,2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010018,"
(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)","
Received",2020-11-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010018,"
(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)", Revised,2020-12-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010018,"
(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)", Accepted,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010018,"
(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)", Published,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010019,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)","
Received",2020-12-04
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010019,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Revised,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010019,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010019,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Published,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010020,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)","
Received",2020-11-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010020,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010020,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Accepted,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010020,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Published,2020-12-29
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010021,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)","
Received",2020-11-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010021,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Revised,2020-12-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010021,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Accepted,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010021,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Published,2020-12-29
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010022,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)","
Received",2020-12-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010022,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Revised,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010022,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Accepted,2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010022,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010023,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)","
Received",2020-11-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010023,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Revised,2020-12-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010023,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Accepted,2020-12-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010023,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010024,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010024,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010024,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010024,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010025,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)","
Received",2020-11-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010025,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Revised,2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010025,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Accepted,2020-12-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010025,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010026,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)","
Received",2020-09-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010026,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Revised,2020-11-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010026,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Accepted,2020-11-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010026,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010027,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2020-12-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010027,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010027,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010027,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010028,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-11-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010028,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2020-12-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010028,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2020-12-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010028,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010029,"
(This article belongs to the Special Issue Edaravone for the Treatment of Amyotrophic Lateral Sclerosis)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010029,"
(This article belongs to the Special Issue Edaravone for the Treatment of Amyotrophic Lateral Sclerosis)", Revised,2020-12-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010029,"
(This article belongs to the Special Issue Edaravone for the Treatment of Amyotrophic Lateral Sclerosis)", Accepted,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010029,"
(This article belongs to the Special Issue Edaravone for the Treatment of Amyotrophic Lateral Sclerosis)", Published,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010030,"
(This article belongs to the Section Pharmacology)","
Received",2020-10-26
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010030,"
(This article belongs to the Section Pharmacology)", Revised,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010030,"
(This article belongs to the Section Pharmacology)", Accepted,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010030,"
(This article belongs to the Section Pharmacology)", Published,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010031,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-12-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010031,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010031,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010031,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010032,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-12-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010032,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010032,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010032,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010033,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)","
Received",2020-11-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010033,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Revised,2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010033,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Accepted,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010033,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Published,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010034,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-11-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010034,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010034,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-12-29
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010034,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010035,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)","
Received",2020-12-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010035,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Revised,2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010035,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Accepted,2021-01-04
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010035,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Published,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010036,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-11-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010036,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2021-01-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010036,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2021-01-03
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010036,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010037,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-12-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010037,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2021-01-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010037,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2021-01-03
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010037,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010038,"
(This article belongs to the Section Pharmacology)","
Received",2020-10-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010038,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-04
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010038,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010038,"
(This article belongs to the Section Pharmacology)", Published,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010039,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-11-22
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010039,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010039,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010039,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010040,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)","
Received",2020-12-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010040,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Revised,2021-01-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010040,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Accepted,2021-01-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010040,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Published,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010041,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)","
Received",2020-12-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010041,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Revised,2021-01-03
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010041,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Accepted,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010041,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Published,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010042,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-11-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010042,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2021-01-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010042,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010042,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010043,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-10-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010043,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2020-12-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010043,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010043,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010044,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010044,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-01-02
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010044,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010044,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010045,"
(This article belongs to the Special Issue Lung Injury and Repair)","
Received",2020-12-25
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010045,"
(This article belongs to the Special Issue Lung Injury and Repair)", Revised,2021-01-04
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010045,"
(This article belongs to the Special Issue Lung Injury and Repair)", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010045,"
(This article belongs to the Special Issue Lung Injury and Repair)", Published,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010046,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2020-11-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010046,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010046,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010046,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-01-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010047,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2020-11-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010047,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2020-12-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010047,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010047,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-01-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010048,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)","
Received",2020-12-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010048,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Revised,2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010048,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Accepted,2021-01-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010048,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Published,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010049,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)","
Received",2020-10-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010049,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Revised,2020-10-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010049,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Accepted,2020-11-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010049,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Published,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010050,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-11-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010050,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010050,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010050,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010051,"
(This article belongs to the Special Issue Clinical Development of Cancer Treatment)","
Received",2020-12-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010051,"
(This article belongs to the Special Issue Clinical Development of Cancer Treatment)", Revised,2021-01-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010051,"
(This article belongs to the Special Issue Clinical Development of Cancer Treatment)", Accepted,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010051,"
(This article belongs to the Special Issue Clinical Development of Cancer Treatment)", Published,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010052,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)","
Received",2020-12-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010052,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Revised,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010052,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Accepted,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010052,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Published,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010053,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)","
Received",2020-11-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010053,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Revised,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010053,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Accepted,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010053,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Published,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010054,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010054,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010054,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010054,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010055,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-12-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010055,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-12-29
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010055,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-12-29
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010055,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010056,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-12-23
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010056,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010056,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010057,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)","
Received",2020-12-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010057,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Revised,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010057,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Accepted,2021-01-09
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010057,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Published,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010058,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-12-24
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010058,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010058,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010058,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010059,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2021-01-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010059,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010059,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010059,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010060,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-12-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010060,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2021-01-05
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010060,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010060,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010061,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)","
Received",2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010061,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Revised,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010061,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Accepted,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010061,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Published,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010062,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)","
Received",2020-12-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010062,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Revised,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010062,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010062,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Published,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010063,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)","
Received",2020-12-27
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010063,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Revised,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010063,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010063,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Published,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010064,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2020-11-20
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010064,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010064,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010064,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010065,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)","
Received",2020-12-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010065,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Revised,2021-01-10
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010065,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010065,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Published,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010066,"
(This article belongs to the Special Issue Impacts of Constituent Material Variability on the Performance and Quality of Pharmaceutical Dosage Forms)","
Received",2020-12-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010066,"
(This article belongs to the Special Issue Impacts of Constituent Material Variability on the Performance and Quality of Pharmaceutical Dosage Forms)", Revised,2021-01-07
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010066,"
(This article belongs to the Special Issue Impacts of Constituent Material Variability on the Performance and Quality of Pharmaceutical Dosage Forms)", Accepted,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010066,"
(This article belongs to the Special Issue Impacts of Constituent Material Variability on the Performance and Quality of Pharmaceutical Dosage Forms)", Published,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010067,"
(This article belongs to the Special Issue Development of Colon Targeted Drug Delivery System)","
Received",2020-12-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010067,"
(This article belongs to the Special Issue Development of Colon Targeted Drug Delivery System)", Revised,2021-01-08
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010067,"
(This article belongs to the Special Issue Development of Colon Targeted Drug Delivery System)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010067,"
(This article belongs to the Special Issue Development of Colon Targeted Drug Delivery System)", Published,2021-01-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010068,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2020-12-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010068,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010068,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2021-01-12
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010068,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2021-01-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010069,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-12-31
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010069,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010069,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010069,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2021-01-16
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010070,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2020-12-21
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010070,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010070,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010070,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2021-01-16
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010071,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-12-01
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010071,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2021-01-13
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010071,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010071,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2021-01-17
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010072,"
(This article belongs to the Special Issue Targeting Proline Metabolic Pathway for Regulation of Apoptosis/Autophagy in Cancer)","
Received",2020-12-28
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010072,"
(This article belongs to the Special Issue Targeting Proline Metabolic Pathway for Regulation of Apoptosis/Autophagy in Cancer)", Revised,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010072,"
(This article belongs to the Special Issue Targeting Proline Metabolic Pathway for Regulation of Apoptosis/Autophagy in Cancer)", Accepted,2021-01-15
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010072,"
(This article belongs to the Special Issue Targeting Proline Metabolic Pathway for Regulation of Apoptosis/Autophagy in Cancer)", Published,2021-01-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010073,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-12-30
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010073,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2021-01-14
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010073,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2021-01-18
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010074,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-12-16
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010074,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2021-01-06
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010074,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2021-01-11
Pharmaceuticals,2021,14,1,https://doi.org/10.3390/ph14010074,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020075,"
(This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration)","
Received",2020-11-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020075,"
(This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration)", Revised,2020-12-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020075,"
(This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration)", Accepted,2021-01-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020075,"
(This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration)", Published,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020076,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)","
Received",2021-01-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020076,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Revised,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020076,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Accepted,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020076,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Published,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020077,"
(This article belongs to the Section Pharmacology)","
Received",2020-12-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020077,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020077,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020077,"
(This article belongs to the Section Pharmacology)", Published,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020078,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)","
Received",2020-12-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020078,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Revised,2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020078,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Accepted,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020078,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Published,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020079,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-12-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020079,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2021-01-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020079,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2021-01-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020079,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020080,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-12-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020080,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2021-01-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020080,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2021-01-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020080,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020081,"
(This article belongs to the Section Pharmacology)","
Received",2020-12-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020081,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020081,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020081,"
(This article belongs to the Section Pharmacology)", Published,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020082,Normal Issue,"
Published",2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020083,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)","
Received",2020-12-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020083,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Revised,2021-01-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020083,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Accepted,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020083,"
(This article belongs to the Special Issue Glycopeptide Antibiotics 2021)", Published,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020084,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020084,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020084,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020084,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-01-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020085,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-12-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020085,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2021-01-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020085,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020085,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2021-01-24
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020086,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-11-24
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020086,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2021-01-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020086,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020086,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2021-01-24
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020087,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2021-01-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020087,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020087,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020087,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020088,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)","
Received",2020-12-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020088,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Revised,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020088,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020088,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Published,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020089,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2020-12-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020089,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2021-01-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020089,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020089,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020090,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-12-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020090,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020090,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020090,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020091,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-12-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020091,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020091,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020091,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020092,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)","
Received",2020-12-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020092,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Revised,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020092,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020092,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Published,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020093,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-11-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020093,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020093,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2021-01-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020093,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020094,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020094,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2021-01-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020094,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020095,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2021-01-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020095,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020095,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020095,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020096,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)","
Received",2020-12-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020096,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Revised,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020096,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020096,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020097,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)","
Received",2021-01-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020097,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Revised,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020097,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Accepted,2021-01-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020097,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020098,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-12-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020098,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2021-01-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020098,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2021-01-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020098,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020099,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2021-01-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020099,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020099,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020100,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2020-12-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020100,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020100,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020100,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020101,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020101,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020101,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020101,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020102,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020102,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020102,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020102,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020103,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-12-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020103,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2021-01-24
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020103,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020103,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020104,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-12-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020104,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020104,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020104,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020105,"
(This article belongs to the Section Pharmacology)","
Received",2021-01-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020105,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020105,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020105,"
(This article belongs to the Section Pharmacology)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020106,"
(This article belongs to the Section Pharmacology)","
Received",2020-12-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020106,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020106,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020106,"
(This article belongs to the Section Pharmacology)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020107,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2021-01-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020107,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Revised,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020107,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020107,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020108,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2021-01-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020108,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020108,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020108,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020109,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)","
Received",2020-12-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020109,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Revised,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020109,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Accepted,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020109,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Published,2021-01-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020110,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)","
Received",2021-01-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020110,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Revised,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020110,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Accepted,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020110,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Published,2021-01-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020111,"
(This article belongs to the Section Pharmacology)","
Received",2020-12-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020111,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020111,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020111,"
(This article belongs to the Section Pharmacology)", Published,2021-01-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020112,"
(This article belongs to the Section Pharmacology)","
Received",2021-01-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020112,"
(This article belongs to the Section Pharmacology)", Revised,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020112,"
(This article belongs to the Section Pharmacology)", Accepted,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020112,"
(This article belongs to the Section Pharmacology)", Published,2021-01-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020113,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2020-12-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020113,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2021-01-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020113,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020113,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020114,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)","
Received",2021-01-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020114,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Revised,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020114,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Accepted,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020114,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Published,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020115,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2020-12-24
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020115,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020115,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020115,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020116,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020116,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Revised,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020116,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Accepted,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020116,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Published,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020117,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020117,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020117,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020117,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020118,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)","
Received",2020-12-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020118,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Revised,2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020118,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Accepted,2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020118,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Published,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020119,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2021-01-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020119,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020119,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020119,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020120,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-12-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020120,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020120,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020120,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020121,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)","
Received",2021-01-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020121,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Revised,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020121,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020121,"
(This article belongs to the Special Issue Quadruplex Nucleic Acid Ligands in Drug Discovery)", Published,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020122,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020122,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020122,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020122,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020123,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2021-01-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020123,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020123,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020123,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020124,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)","
Received",2021-01-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020124,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Revised,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020124,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020124,"
(This article belongs to the Special Issue Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions)", Published,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020125,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)","
Received",2020-12-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020125,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Revised,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020125,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Accepted,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020125,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Published,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020126,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2021-01-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020126,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2021-01-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020126,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020126,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020127,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)","
Received",2021-01-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020127,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Revised,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020127,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Accepted,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020127,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Published,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020128,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-11-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020128,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020128,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020128,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020129,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020129,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-01-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020129,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020129,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020130,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-12-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020130,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020130,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020130,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020131,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2020-12-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020131,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020131,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020131,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020132,"

(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020132,"

(This article belongs to the Section Pharmaceutical Technology)", Revised,2021-01-25
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020132,"

(This article belongs to the Section Pharmaceutical Technology)", Accepted,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020132,"

(This article belongs to the Section Pharmaceutical Technology)", Published,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020133,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020133,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020133,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020133,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020134,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-12-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020134,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020134,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020134,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020135,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-01-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020135,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020135,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020135,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020136,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2020-12-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020136,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020136,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020136,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020137,"
(This article belongs to the Special Issue siRNA Therapeutics: From Bench Lab to Clinics)","
Received",2021-01-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020137,"
(This article belongs to the Special Issue siRNA Therapeutics: From Bench Lab to Clinics)", Revised,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020137,"
(This article belongs to the Special Issue siRNA Therapeutics: From Bench Lab to Clinics)", Accepted,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020137,"
(This article belongs to the Special Issue siRNA Therapeutics: From Bench Lab to Clinics)", Published,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020138,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)","
Received",2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020138,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Accepted,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020138,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Published,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020139,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020139,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020139,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020139,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020140,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)","
Received",2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020140,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Accepted,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020140,"
(This article belongs to the Special Issue Adenosine Receptors as Attractive Targets in Human Diseases)", Published,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020141,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)","
Received",2021-01-27
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020141,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)", Accepted,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020141,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)", Published,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020142,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-11-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020142,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-12-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020142,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-12-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020142,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020143,"
(This article belongs to the Special Issue Advances in 3D Printed Drug Controlled Delivery Systems and Biomedical Applications)","
Received",2021-01-28
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020143,"
(This article belongs to the Special Issue Advances in 3D Printed Drug Controlled Delivery Systems and Biomedical Applications)", Revised,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020143,"
(This article belongs to the Special Issue Advances in 3D Printed Drug Controlled Delivery Systems and Biomedical Applications)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020143,"
(This article belongs to the Special Issue Advances in 3D Printed Drug Controlled Delivery Systems and Biomedical Applications)", Published,2021-02-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020144,"
(This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy)","
Received",2021-01-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020144,"
(This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy)", Revised,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020144,"
(This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy)", Accepted,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020144,"
(This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy)", Published,2021-02-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020145,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)","
Received",2021-01-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020145,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020145,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020145,"
(This article belongs to the Collection The Story of Successful Drugs and Recent FDA-Approved Molecules)", Published,2021-02-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020146,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)","
Received",2020-12-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020146,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Revised,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020146,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Accepted,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020146,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Published,2021-02-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020147,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020147,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020147,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020147,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020148,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)","
Received",2020-12-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020148,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Revised,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020148,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020148,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Published,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020149,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2021-01-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020149,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020149,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020149,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020150,Normal Issue,"
Received",2021-01-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020150,Normal Issue, Revised,2021-02-07
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020150,Normal Issue, Accepted,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020150,Normal Issue, Published,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020151,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020151,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Revised,2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020151,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020151,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Published,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020152,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-01-30
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020152,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020152,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020152,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020153,"
(This article belongs to the Special Issue Antiparasitics)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020153,"
(This article belongs to the Special Issue Antiparasitics)", Revised,2021-02-04
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020153,"
(This article belongs to the Special Issue Antiparasitics)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020153,"
(This article belongs to the Special Issue Antiparasitics)", Published,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020154,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)","
Received",2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020154,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020154,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Accepted,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020154,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Published,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020155,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020155,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2021-02-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020155,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020155,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020156,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-12-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020156,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020156,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020156,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-02-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020157,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-12-31
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020157,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020157,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2021-02-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020157,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2021-02-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020158,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))","
Received",2021-01-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020158,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Revised,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020158,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Accepted,2021-02-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020158,"
(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))", Published,2021-02-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020159,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-12-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020159,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020159,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020159,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020160,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2021-01-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020160,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020160,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-02-08
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020160,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020161,"
(This article belongs to the Special Issue Bacteriophages as Therapeutic Delivery Vehicles)","
Received",2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020161,"
(This article belongs to the Special Issue Bacteriophages as Therapeutic Delivery Vehicles)", Revised,2021-02-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020161,"
(This article belongs to the Special Issue Bacteriophages as Therapeutic Delivery Vehicles)", Accepted,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020161,"
(This article belongs to the Special Issue Bacteriophages as Therapeutic Delivery Vehicles)", Published,2021-02-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020162,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020162,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020162,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-02-11
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020162,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020163,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2021-01-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020163,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2021-02-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020163,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020163,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020164,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2021-01-06
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020164,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020164,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2021-02-10
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020164,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020165,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020165,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2021-02-09
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020165,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020165,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020166,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2021-01-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020166,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2021-02-16
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020166,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020166,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2021-02-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020167,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2021-01-12
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020167,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020167,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020167,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2021-02-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020168,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)","
Received",2021-02-01
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020168,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Revised,2021-02-14
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020168,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Accepted,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020168,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Published,2021-02-21
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020169,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2021-01-05
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020169,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020169,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2021-02-18
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020169,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2021-02-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020170,"
(This article belongs to the Special Issue Epigenetic Drugs)","
Received",2021-02-03
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020170,"
(This article belongs to the Special Issue Epigenetic Drugs)", Revised,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020170,"
(This article belongs to the Special Issue Epigenetic Drugs)", Accepted,2021-02-20
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020170,"
(This article belongs to the Special Issue Epigenetic Drugs)", Published,2021-02-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020171,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2021-01-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020171,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2021-02-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020171,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020171,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2021-02-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020172,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2021-02-02
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020172,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020172,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020172,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2021-02-22
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020173,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2021-01-29
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020173,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2021-02-13
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020173,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2021-02-17
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020173,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2021-02-23
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020174,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2021-01-26
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020174,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2021-02-15
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020174,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2021-02-19
Pharmaceuticals,2021,14,2,https://doi.org/10.3390/ph14020174,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030175,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2021-01-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030175,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2021-02-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030175,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030175,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030176,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)","
Received",2020-12-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030176,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Revised,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030176,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Accepted,2021-02-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030176,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030177,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2021-02-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030177,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030177,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030177,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030178,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2021-01-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030178,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2021-02-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030178,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030178,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030179,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)","
Received",2020-12-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030179,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030179,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Accepted,2021-02-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030179,"
(This article belongs to the Special Issue Molecular Pharmacology of 5-HT Receptors)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030180,"
(This article belongs to the Special Issue Promising Anti-inflammatory Medicinal Plants—An Assessment of Bioavailability, Pharmacokinetics, Clinical Efficacy and Overview of New Methodological Approaches)","
Received",2021-01-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030180,"
(This article belongs to the Special Issue Promising Anti-inflammatory Medicinal Plants—An Assessment of Bioavailability, Pharmacokinetics, Clinical Efficacy and Overview of New Methodological Approaches)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030180,"
(This article belongs to the Special Issue Promising Anti-inflammatory Medicinal Plants—An Assessment of Bioavailability, Pharmacokinetics, Clinical Efficacy and Overview of New Methodological Approaches)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030180,"
(This article belongs to the Special Issue Promising Anti-inflammatory Medicinal Plants—An Assessment of Bioavailability, Pharmacokinetics, Clinical Efficacy and Overview of New Methodological Approaches)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030181,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2021-01-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030181,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-02-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030181,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030181,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030182,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)","
Received",2021-01-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030182,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Revised,2021-02-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030182,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Accepted,2021-02-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030182,"
(This article belongs to the Special Issue Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030183,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2021-01-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030183,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-02-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030183,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030183,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030184,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)","
Received",2021-01-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030184,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Revised,2021-02-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030184,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030184,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030185,"
(This article belongs to the Special Issue Mechanisms of Antibiotic Action and Resistance)","
Received",2021-02-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030185,"
(This article belongs to the Special Issue Mechanisms of Antibiotic Action and Resistance)", Revised,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030185,"
(This article belongs to the Special Issue Mechanisms of Antibiotic Action and Resistance)", Accepted,2021-02-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030185,"
(This article belongs to the Special Issue Mechanisms of Antibiotic Action and Resistance)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030186,"
(This article belongs to the Section Pharmacology)","
Received",2021-01-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030186,"
(This article belongs to the Section Pharmacology)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030186,"
(This article belongs to the Section Pharmacology)", Accepted,2021-02-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030186,"
(This article belongs to the Section Pharmacology)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030187,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)","
Received",2021-01-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030187,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Revised,2021-02-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030187,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030187,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030188,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)","
Received",2021-01-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030188,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Revised,2021-02-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030188,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030188,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030189,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2020-12-31
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030189,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030189,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030189,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030190,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)","
Received",2021-01-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030190,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030190,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030190,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Published,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030191,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2021-01-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030191,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030191,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030191,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030192,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2021-02-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030192,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030192,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030192,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030193,Normal Issue,"
Received",2020-08-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030193,Normal Issue, Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030193,Normal Issue, Published,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030194,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2021-01-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030194,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2021-02-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030194,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030194,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030195,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030195,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030195,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030196,"
(This article belongs to the Special Issue Drug Discovery and Development for Tropical Diseases (TDs))","
Received",2021-02-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030196,"
(This article belongs to the Special Issue Drug Discovery and Development for Tropical Diseases (TDs))", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030196,"
(This article belongs to the Special Issue Drug Discovery and Development for Tropical Diseases (TDs))", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030196,"
(This article belongs to the Special Issue Drug Discovery and Development for Tropical Diseases (TDs))", Published,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030197,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-12-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030197,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030197,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030197,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030198,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)","
Received",2021-01-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030198,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Revised,2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030198,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Accepted,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030198,"
(This article belongs to the Special Issue The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling)", Published,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030199,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)","
Received",2021-01-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030199,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Revised,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030199,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Accepted,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030199,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Published,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030200,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)","
Received",2021-01-31
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030200,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030200,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Accepted,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030200,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Published,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030201,"
(This article belongs to the Special Issue Formulations for Wound Healing)","
Received",2021-01-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030201,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Revised,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030201,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Accepted,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030201,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Published,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030202,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-12-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030202,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2021-02-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030202,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030202,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030203,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-12-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030203,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2021-01-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030203,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2021-01-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030203,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030204,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)","
Received",2021-01-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030204,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Revised,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030204,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Accepted,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030204,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Published,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030205,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-02-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030205,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030205,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030205,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030206,"
(This article belongs to the Section Pharmacology)","
Received",2020-12-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030206,"
(This article belongs to the Section Pharmacology)", Revised,2021-02-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030206,"
(This article belongs to the Section Pharmacology)", Accepted,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030206,"
(This article belongs to the Section Pharmacology)", Published,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030207,"
(This article belongs to the Special Issue Cell-Free DNA for the Management of Lymphoma)","
Received",2021-02-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030207,"
(This article belongs to the Special Issue Cell-Free DNA for the Management of Lymphoma)", Revised,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030207,"
(This article belongs to the Special Issue Cell-Free DNA for the Management of Lymphoma)", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030207,"
(This article belongs to the Special Issue Cell-Free DNA for the Management of Lymphoma)", Published,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030208,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2021-01-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030208,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030208,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030208,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030209,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-12-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030209,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030209,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030209,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030210,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2021-02-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030210,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030210,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030210,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030211,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)","
Received",2021-02-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030211,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030211,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Accepted,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030211,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030212,"
(This article belongs to the Special Issue Applications of Micro-Nanosystems in Retinoids Delivery)","
Received",2021-02-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030212,"
(This article belongs to the Special Issue Applications of Micro-Nanosystems in Retinoids Delivery)", Revised,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030212,"
(This article belongs to the Special Issue Applications of Micro-Nanosystems in Retinoids Delivery)", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030212,"
(This article belongs to the Special Issue Applications of Micro-Nanosystems in Retinoids Delivery)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030213,"
(This article belongs to the Special Issue Identification of Phytochemicals and Derivatives against Infectious Diseases)","
Received",2021-02-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030213,"
(This article belongs to the Special Issue Identification of Phytochemicals and Derivatives against Infectious Diseases)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030213,"
(This article belongs to the Special Issue Identification of Phytochemicals and Derivatives against Infectious Diseases)", Accepted,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030213,"
(This article belongs to the Special Issue Identification of Phytochemicals and Derivatives against Infectious Diseases)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030214,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2021-02-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030214,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030214,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030214,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030215,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-12-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030215,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2021-01-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030215,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2021-01-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030215,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030216,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)","
Received",2021-01-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030216,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Revised,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030216,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Accepted,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030216,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Published,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030217,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2021-01-31
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030217,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030217,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030217,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030218,"
(This article belongs to the Special Issue Epigenetic Drugs)","
Received",2021-02-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030218,"
(This article belongs to the Special Issue Epigenetic Drugs)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030218,"
(This article belongs to the Special Issue Epigenetic Drugs)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030218,"
(This article belongs to the Special Issue Epigenetic Drugs)", Published,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030219,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-02-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030219,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030219,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030219,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030220,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)","
Received",2021-01-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030220,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Revised,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030220,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030220,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Published,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030221,"
(This article belongs to the Special Issue Lung Injury and Repair)","
Received",2020-12-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030221,"
(This article belongs to the Special Issue Lung Injury and Repair)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030221,"
(This article belongs to the Special Issue Lung Injury and Repair)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030221,"
(This article belongs to the Special Issue Lung Injury and Repair)", Published,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030222,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2021-02-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030222,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030222,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030222,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030223,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)","
Received",2021-01-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030223,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Revised,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030223,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030223,"
(This article belongs to the Special Issue PPARs: Pharmacological Roles of Agonists and Antagonists in Experimental Models)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030224,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2021-02-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030224,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030224,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030224,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030225,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)","
Received",2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030225,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Revised,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030225,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030225,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030226,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030226,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030226,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030226,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030227,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)","
Received",2021-01-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030227,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Revised,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030227,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030227,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030228,"
(This article belongs to the Section Pharmacology)","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030228,"
(This article belongs to the Section Pharmacology)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030228,"
(This article belongs to the Section Pharmacology)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030228,"
(This article belongs to the Section Pharmacology)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030229,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030229,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Revised,2021-02-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030229,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Accepted,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030229,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Published,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030230,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2021-02-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030230,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2021-02-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030230,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030230,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030231,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)","
Received",2021-02-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030231,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Revised,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030231,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030231,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030232,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)","
Received",2021-02-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030232,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030232,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030232,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030233,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)","
Received",2020-12-30
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030233,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Revised,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030233,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Accepted,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030233,"
(This article belongs to the Special Issue New Therapies for Hepatocellular Carcinoma)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030234,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2021-02-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030234,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030234,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030234,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030235,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)","
Received",2021-02-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030235,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030235,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030235,"
(This article belongs to the Special Issue Non-coding RNA in Hematological Cancers)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030236,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2021-02-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030236,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030236,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030236,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030237,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)","
Received",2021-01-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030237,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Revised,2021-02-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030237,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Accepted,2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030237,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030238,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2021-01-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030238,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030238,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030238,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030239,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2021-01-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030239,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2021-02-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030239,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030239,"
(This article belongs to the Section Biopharmaceuticals)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030240,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2021-02-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030240,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030240,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030240,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030241,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-02-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030241,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030241,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030241,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030242,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2021-02-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030242,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030242,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030242,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030243,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2021-02-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030243,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2021-02-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030243,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030243,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030244,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)","
Received",2021-02-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030244,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030244,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030244,"
(This article belongs to the Special Issue Applications of Medicinal Bioinorganic Chemistry)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030245,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)","
Received",2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030245,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Revised,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030245,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Accepted,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030245,"
(This article belongs to the Special Issue Monoclonal Antibodies for Migraine Prevention)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030246,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2021-01-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030246,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030246,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030246,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030247,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)","
Received",2021-02-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030247,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030247,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Accepted,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030247,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030248,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)","
Received",2021-01-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030248,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Revised,2021-02-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030248,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Accepted,2021-02-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030248,"
(This article belongs to the Special Issue Natural Compounds as Potential Antimalarial Agents, 2020)", Published,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030249,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030249,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030249,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030249,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030250,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2021-01-30
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030250,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2021-02-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030250,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030250,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030251,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)","
Received",2021-01-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030251,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030251,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Accepted,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030251,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Published,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030252,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030252,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030252,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030252,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030253,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)","
Received",2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030253,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Revised,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030253,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Accepted,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030253,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Published,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030254,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2021-02-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030254,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030254,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030254,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030255,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)","
Received",2020-12-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030255,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Revised,2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030255,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Accepted,2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030255,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Published,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030256,"
(This article belongs to the Section Radiopharmaceutical Sciences)","
Received",2021-02-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030256,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Revised,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030256,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Accepted,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030256,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Published,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030257,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2021-01-25
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030257,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030257,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030257,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030258,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2021-01-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030258,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2021-03-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030258,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030258,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030259,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2021-02-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030259,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030259,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030259,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030260,"
(This article belongs to the Special Issue Osteosarcomas: Treatment Strategies)","
Received",2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030260,"
(This article belongs to the Special Issue Osteosarcomas: Treatment Strategies)", Accepted,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030260,"
(This article belongs to the Special Issue Osteosarcomas: Treatment Strategies)", Published,2021-03-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030261,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)","
Received",2021-01-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030261,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Revised,2021-03-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030261,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Accepted,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030261,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030262,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)","
Received",2020-12-31
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030262,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Revised,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030262,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Accepted,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030262,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030263,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2021-02-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030263,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030263,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030263,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030264,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)","
Received",2021-01-29
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030264,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Revised,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030264,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Accepted,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030264,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030265,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2021-02-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030265,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-03-03
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030265,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030265,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030266,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2021-02-07
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030266,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030266,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030266,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030267,"
(This article belongs to the Section Pharmacology)","
Received",2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030267,"
(This article belongs to the Section Pharmacology)", Revised,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030267,"
(This article belongs to the Section Pharmacology)", Accepted,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030267,"
(This article belongs to the Section Pharmacology)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030268,"
(This article belongs to the Special Issue Antiparasitics)","
Received",2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030268,"
(This article belongs to the Special Issue Antiparasitics)", Revised,2021-03-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030268,"
(This article belongs to the Special Issue Antiparasitics)", Accepted,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030268,"
(This article belongs to the Special Issue Antiparasitics)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030269,"
(This article belongs to the Section Natural Products)","
Received",2021-02-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030269,"
(This article belongs to the Section Natural Products)", Revised,2021-03-06
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030269,"
(This article belongs to the Section Natural Products)", Accepted,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030269,"
(This article belongs to the Section Natural Products)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030270,"
(This article belongs to the Special Issue Searching for New Therapeutic Targets with Anti-Obesity Potential)","
Received",2021-02-02
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030270,"
(This article belongs to the Special Issue Searching for New Therapeutic Targets with Anti-Obesity Potential)", Revised,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030270,"
(This article belongs to the Special Issue Searching for New Therapeutic Targets with Anti-Obesity Potential)", Accepted,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030270,"
(This article belongs to the Special Issue Searching for New Therapeutic Targets with Anti-Obesity Potential)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030271,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)","
Received",2021-02-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030271,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Revised,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030271,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Accepted,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030271,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030272,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2021-01-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030272,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030272,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030272,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030273,"
(This article belongs to the Section Pharmacology)","
Received",2021-02-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030273,"
(This article belongs to the Section Pharmacology)", Revised,2021-03-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030273,"
(This article belongs to the Section Pharmacology)", Accepted,2021-03-12
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030273,"
(This article belongs to the Section Pharmacology)", Published,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030274,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2021-01-26
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030274,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2021-03-01
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030274,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2021-03-04
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030274,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030275,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2021-02-09
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030275,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2021-03-11
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030275,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030275,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030276,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)","
Received",2021-01-28
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030276,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Revised,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030276,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Accepted,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030276,"
(This article belongs to the Special Issue Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations)", Published,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030277,"
(This article belongs to the Special Issue Molecular Imaging in Neurology and Oncology: Radiopharmaceuticals for PET and SPECT)","
Received",2021-02-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030277,"
(This article belongs to the Special Issue Molecular Imaging in Neurology and Oncology: Radiopharmaceuticals for PET and SPECT)", Revised,2021-03-10
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030277,"
(This article belongs to the Special Issue Molecular Imaging in Neurology and Oncology: Radiopharmaceuticals for PET and SPECT)", Accepted,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030277,"
(This article belongs to the Special Issue Molecular Imaging in Neurology and Oncology: Radiopharmaceuticals for PET and SPECT)", Published,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030278,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)","
Received",2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030278,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Revised,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030278,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Accepted,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030278,"
(This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective)", Published,2021-03-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030279,Normal Issue,"
Received",2021-02-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030279,Normal Issue, Revised,2021-03-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030279,Normal Issue, Accepted,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030279,Normal Issue, Published,2021-03-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030280,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2021-02-24
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030280,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030280,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030280,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2021-03-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030281,"
(This article belongs to the Special Issue Pharmacology and Medical Uses of Citicoline)","
Received",2021-02-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030281,"
(This article belongs to the Special Issue Pharmacology and Medical Uses of Citicoline)", Revised,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030281,"
(This article belongs to the Special Issue Pharmacology and Medical Uses of Citicoline)", Accepted,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030281,"
(This article belongs to the Special Issue Pharmacology and Medical Uses of Citicoline)", Published,2021-03-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030282,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)","
Received",2021-02-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030282,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)", Revised,2021-03-15
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030282,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)", Accepted,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030282,"
(This article belongs to the Special Issue In Silico Approaches in Drug Design 2021)", Published,2021-03-21
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030283,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2021-01-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030283,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2021-03-17
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030283,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2021-03-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030283,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2021-03-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030284,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)","
Received",2021-02-27
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030284,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Revised,2021-03-16
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030284,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Accepted,2021-03-19
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030284,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Published,2021-03-22
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030285,Normal Issue,"
Received",2021-02-14
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030285,Normal Issue, Revised,2021-03-05
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030285,Normal Issue, Accepted,2021-03-18
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030285,Normal Issue, Published,2021-03-23
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030286,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2021-02-08
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030286,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2021-03-13
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030286,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2021-03-20
Pharmaceuticals,2021,14,3,https://doi.org/10.3390/ph14030286,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2021-03-23
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040287,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)","
Received",2021-03-02
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040287,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Revised,2021-03-19
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040287,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Accepted,2021-03-21
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040287,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Published,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040288,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)","
Received",2021-01-31
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040288,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Revised,2021-03-15
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040288,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Accepted,2021-03-19
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040288,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Published,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040289,"
(This article belongs to the Special Issue Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities)","
Received",2021-02-27
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040289,"
(This article belongs to the Special Issue Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities)", Revised,2021-03-18
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040289,"
(This article belongs to the Special Issue Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities)", Accepted,2021-03-23
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040289,"
(This article belongs to the Special Issue Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities)", Published,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040290,"
(This article belongs to the Section Pharmacology)","
Received",2021-02-10
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040290,"
(This article belongs to the Section Pharmacology)", Revised,2021-03-16
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040290,"
(This article belongs to the Section Pharmacology)", Accepted,2021-03-22
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040290,"
(This article belongs to the Section Pharmacology)", Published,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040291,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)","
Received",2021-02-15
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040291,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Revised,2021-03-16
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040291,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Accepted,2021-03-23
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040291,"
(This article belongs to the Special Issue New Frontiers in Cyclodextrin Technologies)", Published,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040292,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2021-02-18
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040292,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2021-03-14
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040292,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2021-03-16
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040292,"
(This article belongs to the Section Medicinal Chemistry)", Published,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040293,"
(This article belongs to the Special Issue Pharmacology of Neuropeptide S Receptor)","
Received",2021-02-16
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040293,"
(This article belongs to the Special Issue Pharmacology of Neuropeptide S Receptor)", Revised,2021-03-22
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040293,"
(This article belongs to the Special Issue Pharmacology of Neuropeptide S Receptor)", Accepted,2021-03-23
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040293,"
(This article belongs to the Special Issue Pharmacology of Neuropeptide S Receptor)", Published,2021-03-26
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040294,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2021-03-04
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040294,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2021-03-19
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040294,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040294,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2021-03-26
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040295,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)","
Received",2021-03-09
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040295,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Revised,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040295,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Accepted,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040295,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Published,2021-03-26
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040296,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)","
Received",2021-03-10
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040296,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Revised,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040296,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040296,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Published,2021-03-26
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040297,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2021-02-12
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040297,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2021-03-05
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040297,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2021-03-13
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040297,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2021-03-27
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040298,Normal Issue,"
Received",2021-03-17
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040298,Normal Issue, Revised,2021-03-23
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040298,Normal Issue, Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040298,Normal Issue, Published,2021-03-27
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040299,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)","
Received",2021-02-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040299,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Revised,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040299,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040299,"
(This article belongs to the Special Issue Drugs and Treatments for Inflammatory Bowel Diseases)", Published,2021-03-28
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040300,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)","
Received",2021-02-13
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040300,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Revised,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040300,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040300,"
(This article belongs to the Special Issue Targets, Tracers and Translation, Part 2 - New Horizons in Radiopharmaceutical Development)", Published,2021-03-28
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040301,"
(This article belongs to the Special Issue Formulations for Wound Healing)","
Received",2021-03-02
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040301,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Revised,2021-03-21
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040301,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Accepted,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040301,"
(This article belongs to the Special Issue Formulations for Wound Healing)", Published,2021-03-28
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040302,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)","
Received",2021-02-19
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040302,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Revised,2021-03-21
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040302,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040302,"
(This article belongs to the Special Issue Novel Translational Approaches to the Treatment of Coronary Artery Disease and Congenital Heart Disease in Comorbid Patients)", Published,2021-03-28
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040303,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)","
Received",2021-03-03
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040303,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Revised,2021-03-24
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040303,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Accepted,2021-03-25
Pharmaceuticals,2021,14,4,https://doi.org/10.3390/ph14040303,"
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)", Published,2021-03-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100264,"
(This article belongs to the Section Pharmacology)","
Received",2020-09-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100264,"
(This article belongs to the Section Pharmacology)", Revised,2020-09-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100264,"
(This article belongs to the Section Pharmacology)", Accepted,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100264,"
(This article belongs to the Section Pharmacology)", Published,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100265,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)","
Received",2020-08-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100265,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Revised,2020-09-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100265,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Accepted,2020-09-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100265,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Published,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100266,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-08-06
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100266,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-09-04
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100266,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100266,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100267,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-09-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100267,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-09-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100267,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100268,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-09-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100268,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100268,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100268,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100269,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100269,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100269,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100269,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100270,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-09-06
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100270,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100270,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100270,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100271,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-08-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100271,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-09-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100271,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100271,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100272,"
(This article belongs to the Section Radiopharmaceutical Sciences)","
Received",2020-08-31
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100272,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Revised,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100272,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Accepted,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100272,"
(This article belongs to the Section Radiopharmaceutical Sciences)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100273,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-09-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100273,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-09-18
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100273,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100273,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100274,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)","
Received",2020-09-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100274,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Revised,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100274,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Accepted,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100274,"
(This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100275,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)","
Received",2020-07-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100275,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Revised,2020-09-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100275,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Accepted,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100275,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Published,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100276,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-08-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100276,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100276,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100276,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100277,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-08-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100277,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100277,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100277,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100278,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-09-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100278,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100278,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100278,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100279,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-08-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100279,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100279,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100279,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100280,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-08-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100280,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100280,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100280,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100281,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-08-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100281,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100281,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-09-27
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100281,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100282,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-08-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100282,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100282,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-09-27
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100282,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100283,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-08-05
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100283,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100283,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100283,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100284,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-07-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100284,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100284,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100284,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100285,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100285,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100285,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100285,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100286,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)","
Received",2020-09-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100286,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Revised,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100286,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Accepted,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100286,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Published,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100287,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)","
Received",2020-09-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100287,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)", Accepted,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100287,"
(This article belongs to the Special Issue Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers)", Published,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100288,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-08-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100288,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-09-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100288,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-09-18
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100288,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-10-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100289,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)","
Received",2020-09-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100289,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100289,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Accepted,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100289,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Published,2020-10-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100290,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100290,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100290,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-09-27
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100290,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100291,"
(This article belongs to the Section Natural Products)","
Received",2020-08-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100291,"
(This article belongs to the Section Natural Products)", Revised,2020-08-31
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100291,"
(This article belongs to the Section Natural Products)", Accepted,2020-09-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100291,"
(This article belongs to the Section Natural Products)", Published,2020-10-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100292,"
(This article belongs to the Section Pharmacology)","
Received",2020-08-23
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100292,"
(This article belongs to the Section Pharmacology)", Revised,2020-10-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100292,"
(This article belongs to the Section Pharmacology)", Accepted,2020-10-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100292,"
(This article belongs to the Section Pharmacology)", Published,2020-10-05
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100293,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-07-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100293,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100293,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-10-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100293,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-10-06
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100294,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-08-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100294,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100294,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2020-10-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100294,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2020-10-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100295,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-02
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100295,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100295,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100295,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100296,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-08-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100296,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-09-18
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100296,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-10-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100296,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100297,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2020-08-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100297,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100297,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2020-09-28
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100297,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100298,"
(This article belongs to the Section Pharmacology)","
Received",2020-07-31
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100298,"
(This article belongs to the Section Pharmacology)", Revised,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100298,"
(This article belongs to the Section Pharmacology)", Accepted,2020-10-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100298,"
(This article belongs to the Section Pharmacology)", Published,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100299,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100299,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100299,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100299,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100300,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-09-04
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100300,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100300,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2020-10-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100300,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100301,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-09-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100301,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-10-05
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100301,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100301,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100302,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-11
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100302,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100302,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100302,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100303,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-09-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100303,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-10-04
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100303,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100303,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100304,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-09-04
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100304,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100304,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100304,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100305,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)","
Received",2020-09-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100305,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Revised,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100305,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Accepted,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100305,"
(This article belongs to the Special Issue The Pharmacogenomics of Mood Stabilizers)", Published,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100306,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-09-27
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100306,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100306,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100306,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100307,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-09-18
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100307,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-10-04
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100307,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100307,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100308,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-09-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100308,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-09-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100308,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100308,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100309,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2020-09-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100309,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100309,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100309,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100310,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)","
Received",2020-09-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100310,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Revised,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100310,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Accepted,2020-10-11
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100310,"
(This article belongs to the Special Issue Natural Pharmacons: Biologically Active Plant Based Pharmaceuticals)", Published,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100311,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100311,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100311,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100311,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100312,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-08-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100312,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100312,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100312,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100313,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-09-18
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100313,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-10-11
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100313,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100313,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100314,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-09-11
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100314,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-10-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100314,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100314,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100315,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-06-30
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100315,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100315,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-09-24
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100315,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-10-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100316,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)","
Received",2020-10-01
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100316,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Revised,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100316,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Accepted,2020-10-13
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100316,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Published,2020-10-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100317,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-09-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100317,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-10-12
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100317,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100317,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-10-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100318,"
(This article belongs to the Section Pharmacology)","
Received",2020-09-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100318,"
(This article belongs to the Section Pharmacology)", Revised,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100318,"
(This article belongs to the Section Pharmacology)", Accepted,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100318,"
(This article belongs to the Section Pharmacology)", Published,2020-10-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100319,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-09-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100319,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-10-08
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100319,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100319,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-10-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100320,"
(This article belongs to the Section Natural Products)","
Received",2020-09-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100320,"
(This article belongs to the Section Natural Products)", Revised,2020-09-25
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100320,"
(This article belongs to the Section Natural Products)", Accepted,2020-09-27
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100320,"
(This article belongs to the Section Natural Products)", Published,2020-10-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100321,"
(This article belongs to the Special Issue Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmias)","
Received",2020-09-29
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100321,"
(This article belongs to the Special Issue Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmias)", Revised,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100321,"
(This article belongs to the Special Issue Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmias)", Accepted,2020-10-16
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100321,"
(This article belongs to the Special Issue Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmias)", Published,2020-10-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100322,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2020-09-11
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100322,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2020-10-14
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100322,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2020-10-15
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100322,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2020-10-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100323,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)","
Received",2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100323,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Revised,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100323,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Accepted,2020-10-19
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100323,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Published,2020-10-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100324,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2020-08-07
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100324,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2020-10-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100324,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2020-10-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100324,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2020-10-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100325,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)","
Received",2020-09-03
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100325,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Revised,2020-10-10
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100325,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Accepted,2020-10-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100325,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Published,2020-10-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100326,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)","
Received",2020-09-22
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100326,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Revised,2020-10-17
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100326,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Accepted,2020-10-20
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100326,"
(This article belongs to the Special Issue New Drugs and Biologics For Treatment of Central Nervous Dysfunction)", Published,2020-10-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100327,"
 (This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-08-26
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100327,"
 (This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-09-21
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100327,"
 (This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-10-09
Pharmaceuticals,2020,13,10,https://doi.org/10.3390/ph13100327,"
 (This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110328,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-08-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110328,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110328,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110328,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110329,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2020-09-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110329,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2020-10-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110329,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110329,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110330,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110330,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-10-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110330,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110330,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110331,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110331,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-10-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110331,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110331,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110332,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-09-24
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110332,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110332,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110332,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110333,"
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Pediatric Diseases)","
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110333,"
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Pediatric Diseases)", Revised,2020-10-18
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110333,"
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Pediatric Diseases)", Accepted,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110333,"
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Pediatric Diseases)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110334,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)","
Received",2020-09-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110334,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Revised,2020-10-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110334,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Accepted,2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110334,"
(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110335,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-09-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110335,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110335,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110335,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110336,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-08-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110336,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110336,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110336,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110337,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)","
Received",2020-09-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110337,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110337,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110337,"
(This article belongs to the Special Issue Cannabidiol: Advances in Therapeutic Applications and Future Perspectives)", Published,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110338,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-09-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110338,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110338,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110338,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-10-24
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110339,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110339,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110339,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-10-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110339,"
 (This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-10-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110340,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)","
Received",2020-09-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110340,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Revised,2020-10-18
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110340,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Accepted,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110340,"
(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications 2021)", Published,2020-10-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110341,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-09-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110341,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110341,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110341,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110342,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110342,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110342,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110342,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110343,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110343,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-10-07
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110343,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110343,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110344,"
(This article belongs to the Special Issue Drug Screening or Drug Designing Based on Stem Cell Models)","
Received",2020-08-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110344,"
(This article belongs to the Special Issue Drug Screening or Drug Designing Based on Stem Cell Models)", Revised,2020-10-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110344,"
(This article belongs to the Special Issue Drug Screening or Drug Designing Based on Stem Cell Models)", Accepted,2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110344,"
(This article belongs to the Special Issue Drug Screening or Drug Designing Based on Stem Cell Models)", Published,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110345,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)","
Received",2020-09-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110345,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Revised,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110345,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110345,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Published,2020-10-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110346,"
(This article belongs to the Special Issue Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets)","
Received",2020-09-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110346,"
(This article belongs to the Special Issue Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets)", Revised,2020-10-01
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110346,"
(This article belongs to the Special Issue Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets)", Accepted,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110346,"
(This article belongs to the Special Issue Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets)", Published,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110347,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)","
Received",2020-09-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110347,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Revised,2020-10-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110347,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Accepted,2020-10-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110347,"
(This article belongs to the Special Issue Kinins and Their Receptors as Potential Therapeutic Targets —— A Tribute to Professor Domenico Regoli, A Key Figure in the Field of Kinins)", Published,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110348,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)","
Received",2020-09-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110348,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Revised,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110348,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110348,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Published,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110349,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110349,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Revised,2020-10-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110349,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110349,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110350,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)","
Received",2020-09-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110350,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Revised,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110350,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110350,"
(This article belongs to the Special Issue Photodynamic Therapy 2021)", Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110351,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110351,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110351,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-10-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110351,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110352,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110352,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110352,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110352,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110353,Normal Issue,"
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110353,Normal Issue, Revised,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110353,Normal Issue, Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110353,Normal Issue, Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110354,"
(This article belongs to the Special Issue Lung Injury and Repair)","
Received",2020-10-01
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110354,"
(This article belongs to the Special Issue Lung Injury and Repair)", Revised,2020-10-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110354,"
(This article belongs to the Special Issue Lung Injury and Repair)", Accepted,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110354,"
(This article belongs to the Special Issue Lung Injury and Repair)", Published,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110355,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-09-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110355,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110355,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-10-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110355,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110356,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)","
Received",2020-10-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110356,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Revised,2020-10-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110356,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Accepted,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110356,"
(This article belongs to the Special Issue Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders)", Published,2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110357,"
(This article belongs to the Section Natural Products)","
Received",2020-09-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110357,"
(This article belongs to the Section Natural Products)", Revised,2020-10-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110357,"
(This article belongs to the Section Natural Products)", Accepted,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110357,"
(This article belongs to the Section Natural Products)", Published,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110358,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)","
Received",2020-09-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110358,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Revised,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110358,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Accepted,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110358,"
(This article belongs to the Special Issue Multitarget Drug Discovery and Pharmacology)", Published,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110359,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110359,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Revised,2020-10-25
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110359,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Accepted,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110359,"
(This article belongs to the Special Issue Pharmacotherapy of Central Serous Chorioretinopathy)", Published,2020-11-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110360,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-09-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110360,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110360,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110360,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2020-11-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110361,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)","
Received",2020-09-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110361,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Revised,2020-10-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110361,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Accepted,2020-10-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110361,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Published,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110362,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110362,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-10-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110362,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110362,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110363,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-10-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110363,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110363,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110363,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110364,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-10-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110364,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110364,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110364,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110365,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2020-10-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110365,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110365,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110365,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110366,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-10-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110366,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2020-10-28
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110366,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2020-11-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110366,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110367,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110367,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-11-01
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110367,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110367,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110368,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)","
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110368,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Revised,2020-10-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110368,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Accepted,2020-11-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110368,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Published,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110369,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110369,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110369,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110369,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110370,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-10-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110370,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110370,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110370,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110371,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-09-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110371,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110371,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110371,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-11-07
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110372,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)","
Received",2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110372,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Revised,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110372,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Accepted,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110372,"
(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)", Published,2020-11-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110373,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)","
Received",2020-09-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110373,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Revised,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110373,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Accepted,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110373,"
(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)", Published,2020-11-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110374,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-10-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110374,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-11-01
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110374,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110374,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110375,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2020-10-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110375,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110375,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110375,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110376,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)","
Received",2020-10-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110376,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Revised,2020-11-03
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110376,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Accepted,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110376,"
(This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases)", Published,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110377,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-10-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110377,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110377,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110377,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110378,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)","
Received",2020-09-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110378,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Revised,2020-10-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110378,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Accepted,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110378,"
(This article belongs to the Special Issue Immune Checkpoint Inhibitor Therapy)", Published,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110379,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-09-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110379,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110379,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110379,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110380,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-10-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110380,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110380,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110380,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110381,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-10-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110381,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-11-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110381,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110381,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110382,"
(This article belongs to the Special Issue Epigenetic Drugs)","
Received",2020-09-29
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110382,"
(This article belongs to the Special Issue Epigenetic Drugs)", Revised,2020-11-01
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110382,"
(This article belongs to the Special Issue Epigenetic Drugs)", Accepted,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110382,"
(This article belongs to the Special Issue Epigenetic Drugs)", Published,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110383,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-09-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110383,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-11-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110383,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110383,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110384,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110384,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110384,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110384,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110385,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110385,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110385,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110385,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110386,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-10-05
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110386,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110386,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110386,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110387,"
(This article belongs to the Section Pharmacology)","
Received",2020-08-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110387,"
(This article belongs to the Section Pharmacology)", Revised,2020-10-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110387,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110387,"
(This article belongs to the Section Pharmacology)", Published,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110388,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2020-09-26
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110388,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110388,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110388,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110389,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2020-10-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110389,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Revised,2020-11-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110389,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110389,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110390,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110390,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110390,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110390,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110391,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-10-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110391,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110391,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110391,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110392,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-10-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110392,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110392,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110392,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2020-11-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110393,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110393,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110393,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110393,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-11-15
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110394,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)","
Received",2020-10-24
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110394,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Revised,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110394,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Accepted,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110394,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Published,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110395,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-10-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110395,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110395,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110395,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110396,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)","
Received",2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110396,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Accepted,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110396,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Published,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110397,"
(This article belongs to the Section Pharmacology)","
Received",2020-10-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110397,"
(This article belongs to the Section Pharmacology)", Revised,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110397,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110397,"
(This article belongs to the Section Pharmacology)", Published,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110398,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)","
Received",2020-09-27
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110398,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Revised,2020-11-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110398,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Accepted,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110398,"
(This article belongs to the Special Issue Amino Acids Metabolism and Cancer Therapy)", Published,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110399,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-10-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110399,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110399,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110399,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110400,"
(This article belongs to the Special Issue Biosimilars in Europe)","
Received",2020-08-07
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110400,"
(This article belongs to the Special Issue Biosimilars in Europe)", Revised,2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110400,"
(This article belongs to the Special Issue Biosimilars in Europe)", Accepted,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110400,"
(This article belongs to the Special Issue Biosimilars in Europe)", Published,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110401,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)","
Received",2020-10-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110401,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Revised,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110401,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Accepted,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110401,"
(This article belongs to the Special Issue Therapeutic Agents for Neurological Disorders)", Published,2020-11-18
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110402,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-10-08
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110402,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-10-31
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110402,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-11-04
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110402,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110403,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)","
Received",2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110403,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Revised,2020-11-09
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110403,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110403,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Published,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110404,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))","
Received",2020-10-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110404,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Revised,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110404,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Accepted,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110404,"
(This article belongs to the Special Issue Selected Papers from the 6th International Electronic Conference on Medicinal Chemistry (ECMC2020))", Published,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110405,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110405,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2020-11-14
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110405,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110405,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110406,"
(This article belongs to the Section Pharmacology)","
Received",2020-10-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110406,"
(This article belongs to the Section Pharmacology)", Revised,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110406,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110406,"
(This article belongs to the Section Pharmacology)", Published,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110407,"
(This article belongs to the Section Pharmacology)","
Received",2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110407,"
(This article belongs to the Section Pharmacology)", Revised,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110407,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110407,"
(This article belongs to the Section Pharmacology)", Published,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110408,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)","
Received",2020-10-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110408,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Revised,2020-11-10
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110408,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Accepted,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110408,"
(This article belongs to the Special Issue Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications)", Published,2020-11-21
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110409,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2020-10-02
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110409,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2020-11-11
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110409,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2020-11-12
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110409,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2020-11-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110410,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110410,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110410,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110410,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-11-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110411,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110411,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-11-16
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110411,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110411,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-11-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110412,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)","
Received",2020-10-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110412,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Revised,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110412,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110412,"
(This article belongs to the Special Issue Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products)", Published,2020-11-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110413,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110413,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110413,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110413,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-11-22
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110414,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2020-10-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110414,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2020-11-17
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110414,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2020-11-18
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110414,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2020-11-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110415,"
(This article belongs to the Special Issue Lung Injury and Repair)","
Received",2020-11-06
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110415,"
(This article belongs to the Special Issue Lung Injury and Repair)", Revised,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110415,"
(This article belongs to the Special Issue Lung Injury and Repair)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110415,"
(This article belongs to the Special Issue Lung Injury and Repair)", Published,2020-11-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110416,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)","
Received",2020-10-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110416,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Revised,2020-11-13
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110416,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110416,"
(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)", Published,2020-11-23
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110417,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)","
Received",2020-09-30
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110417,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Revised,2020-11-19
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110417,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Accepted,2020-11-20
Pharmaceuticals,2020,13,11,https://doi.org/10.3390/ph13110417,"
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)", Published,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120418,"
(This article belongs to the Collection Protein Kinases and Cancer)","
Received",2020-10-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120418,"
(This article belongs to the Collection Protein Kinases and Cancer)", Revised,2020-11-20
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120418,"
(This article belongs to the Collection Protein Kinases and Cancer)", Accepted,2020-11-22
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120418,"
(This article belongs to the Collection Protein Kinases and Cancer)", Published,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120419,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)","
Received",2020-10-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120419,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Revised,2020-11-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120419,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Accepted,2020-11-20
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120419,"
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancer)", Published,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120420,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)","
Received",2020-10-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120420,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Revised,2020-11-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120420,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Accepted,2020-11-20
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120420,"
(This article belongs to the Special Issue Featured Papers to Celebrate the New Era of the Journal Pharmaceuticals)", Published,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120421,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-10-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120421,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-11-13
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120421,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120421,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120422,"
(This article belongs to the Special Issue Statins Use and Cancer)","
Received",2020-10-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120422,"
(This article belongs to the Special Issue Statins Use and Cancer)", Revised,2020-11-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120422,"
(This article belongs to the Special Issue Statins Use and Cancer)", Accepted,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120422,"
(This article belongs to the Special Issue Statins Use and Cancer)", Published,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120423,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-10-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120423,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-11-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120423,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120423,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120424,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)","
Received",2020-09-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120424,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Revised,2020-11-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120424,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Accepted,2020-11-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120424,"
(This article belongs to the Special Issue Treatment of Alzheimer Disease)", Published,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120425,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-10-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120425,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-11-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120425,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120425,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120426,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)","
Received",2020-11-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120426,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Revised,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120426,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Accepted,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120426,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Published,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120427,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-10-31
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120427,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120427,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120427,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120428,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-11-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120428,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120428,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120428,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120429,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))","
Received",2020-10-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120429,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Revised,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120429,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Accepted,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120429,"
(This article belongs to the Special Issue Drug and Therapy for Osteoarthritis (OA))", Published,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120430,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)","
Received",2020-10-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120430,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Revised,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120430,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Accepted,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120430,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Published,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120431,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)","
Received",2020-10-31
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120431,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Revised,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120431,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Accepted,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120431,"
(This article belongs to the Collection Old Pharmaceuticals with New Applications)", Published,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120432,"
(This article belongs to the Section Pharmacology)","
Received",2020-09-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120432,"
(This article belongs to the Section Pharmacology)", Revised,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120432,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120432,"
(This article belongs to the Section Pharmacology)", Published,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120433,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-10-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120433,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120433,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120433,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120434,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-09-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120434,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-11-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120434,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120434,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120435,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)","
Received",2020-11-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120435,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Revised,2020-11-25
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120435,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Accepted,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120435,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Published,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120436,"
(This article belongs to the Special Issue Next Generation of MRI Agents)","
Received",2020-11-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120436,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Revised,2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120436,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Accepted,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120436,"
(This article belongs to the Special Issue Next Generation of MRI Agents)", Published,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120437,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)","
Received",2020-11-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120437,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Revised,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120437,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Accepted,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120437,"
(This article belongs to the Special Issue GPCRs: Ligands and beyond 2020)", Published,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120438,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)","
Received",2020-11-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120438,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Revised,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120438,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Accepted,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120438,"
(This article belongs to the Special Issue MiRNA-Based Therapeutics in Cancer)", Published,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120439,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2020-10-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120439,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120439,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120439,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2020-12-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120440,"
(This article belongs to the Special Issue Antiparasitics)","
Received",2020-10-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120440,"
(This article belongs to the Special Issue Antiparasitics)", Revised,2020-11-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120440,"
(This article belongs to the Special Issue Antiparasitics)", Accepted,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120440,"
(This article belongs to the Special Issue Antiparasitics)", Published,2020-12-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120441,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-11-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120441,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120441,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120441,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-12-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120442,"
(This article belongs to the Section Biopharmaceuticals)","
Received",2020-11-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120442,"
(This article belongs to the Section Biopharmaceuticals)", Revised,2020-11-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120442,"
(This article belongs to the Section Biopharmaceuticals)", Accepted,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120442,"
(This article belongs to the Section Biopharmaceuticals)", Published,2020-12-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120443,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-10-22
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120443,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120443,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120443,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120444,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-11-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120444,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-12-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120444,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-12-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120444,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120445,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)","
Received",2020-11-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120445,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Revised,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120445,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Accepted,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120445,"
(This article belongs to the Special Issue New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis)", Published,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120446,"

(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-10-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120446,"

(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120446,"

(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-12-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120446,"

(This article belongs to the Section Pharmaceutical Technology)", Published,2020-12-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120447,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)","
Received",2020-10-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120447,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Revised,2020-11-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120447,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Accepted,2020-11-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120447,"
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)", Published,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120448,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)","
Received",2020-10-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120448,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Revised,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120448,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Accepted,2020-12-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120448,"
(This article belongs to the Special Issue Advances in Ocular Pharmacology)", Published,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120449,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)","
Received",2020-10-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120449,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Revised,2020-11-28
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120449,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Accepted,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120449,"
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases 2020)", Published,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120450,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)","
Received",2020-10-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120450,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Revised,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120450,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Accepted,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120450,"
(This article belongs to the Special Issue Anti-cancer Drugs Induced Toxicity and Interventions 2021)", Published,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120451,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)","
Received",2020-11-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120451,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Revised,2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120451,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Accepted,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120451,"
(This article belongs to the Special Issue Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma)", Published,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120452,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)","
Received",2020-10-31
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120452,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Revised,2020-12-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120452,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Accepted,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120452,"
(This article belongs to the Special Issue Metformin: Mechanism and Application 2020)", Published,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120453,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-11-23
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120453,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-12-07
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120453,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120453,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120454,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2020-11-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120454,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2020-12-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120454,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120454,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120455,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)","
Received",2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120455,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Revised,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120455,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Accepted,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120455,"
(This article belongs to the Special Issue Supportive and Palliative Cancer Treatment)", Published,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120456,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)","
Received",2020-11-19
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120456,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Revised,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120456,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Accepted,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120456,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Published,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120457,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)","
Received",2020-11-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120457,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Revised,2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120457,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Accepted,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120457,"
(This article belongs to the Special Issue Molecular and Cellular Targets of Old and New Atypical Antipsychotics)", Published,2020-12-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120458,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)","
Received",2020-10-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120458,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Revised,2020-12-07
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120458,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Accepted,2020-12-07
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120458,"
(This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences)", Published,2020-12-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120459,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)","
Received",2020-11-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120459,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Revised,2020-12-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120459,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120459,"
(This article belongs to the Special Issue Clinical and Forensic Toxicology: The Latest Updates)", Published,2020-12-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120460,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)","
Received",2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120460,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Revised,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120460,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120460,"
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)", Published,2020-12-13
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120461,"
(This article belongs to the Section Medicinal Chemistry)","
Received",2020-09-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120461,"
(This article belongs to the Section Medicinal Chemistry)", Revised,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120461,"
(This article belongs to the Section Medicinal Chemistry)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120461,"
(This article belongs to the Section Medicinal Chemistry)", Published,2020-12-13
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120462,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)","
Received",2020-10-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120462,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Revised,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120462,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120462,"
(This article belongs to the Special Issue Antibody-Drug Conjugates (ADC): 2021)", Published,2020-12-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120463,"
(This article belongs to the Section Pharmacology)","
Received",2020-09-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120463,"
(This article belongs to the Section Pharmacology)", Revised,2020-11-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120463,"
(This article belongs to the Section Pharmacology)", Accepted,2020-11-05
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120463,"
(This article belongs to the Section Pharmacology)", Published,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120464,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-10-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120464,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-12-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120464,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-12-04
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120464,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120465,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)","
Received",2020-10-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120465,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Revised,2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120465,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120465,"
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)", Published,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120466,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)","
Received",2020-10-19
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120466,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Revised,2020-12-09
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120466,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Accepted,2020-12-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120466,"
(This article belongs to the Special Issue Pharmacoepidemiology and Pharmacovigilance in Drug-Therapy: New Issues, Challenges, and Applications)", Published,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120467,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)","
Received",2020-10-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120467,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Revised,2020-12-06
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120467,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Accepted,2020-12-12
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120467,"
(This article belongs to the Special Issue Computational Drug Discovery and Development in the Era of Big Data)", Published,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120468,Normal Issue,"
Received",2020-09-07
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120468,Normal Issue, Revised,2020-12-02
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120468,Normal Issue, Accepted,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120468,Normal Issue, Published,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120469,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120469,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120469,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120469,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120470,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)","
Received",2020-11-27
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120470,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Accepted,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120470,"
(This article belongs to the Special Issue Malignant Glioma: Novel Therapeutic Strategies)", Published,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120471,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)","
Received",2020-11-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120471,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Revised,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120471,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Accepted,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120471,"
(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)", Published,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120472,"
(This article belongs to the Special Issue Medicinal Plants 2020)","
Received",2020-11-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120472,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Revised,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120472,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Accepted,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120472,"
(This article belongs to the Special Issue Medicinal Plants 2020)", Published,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120473,"
(This article belongs to the Section Pharmaceutical Technology)","
Received",2020-10-31
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120473,"
(This article belongs to the Section Pharmaceutical Technology)", Revised,2020-12-10
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120473,"
(This article belongs to the Section Pharmaceutical Technology)", Accepted,2020-12-13
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120473,"
(This article belongs to the Section Pharmaceutical Technology)", Published,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120474,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)","
Received",2020-10-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120474,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Revised,2020-12-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120474,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Accepted,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120474,"
(This article belongs to the Special Issue Treatment Options and Therapeutics for Non-small Cell Lung Cancer)", Published,2020-12-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120475,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)","
Received",2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120475,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Revised,2020-12-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120475,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Accepted,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120475,"
(This article belongs to the Special Issue Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals)", Published,2020-12-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120476,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)","
Received",2020-11-03
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120476,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Revised,2020-12-08
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120476,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Accepted,2020-12-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120476,"
(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)", Published,2020-12-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120477,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)","
Received",2020-11-26
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120477,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Revised,2020-12-14
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120477,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Accepted,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120477,"
(This article belongs to the Special Issue Small Molecules as Antimicrobials)", Published,2020-12-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120478,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)","
Received",2020-11-07
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120478,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Revised,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120478,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Accepted,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120478,"
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control 2021)", Published,2020-12-19
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120479,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-10-01
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120479,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120479,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120479,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-12-19
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120480,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)","
Received",2020-11-30
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120480,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Revised,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120480,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Accepted,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120480,"
(This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021)", Published,2020-12-20
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120481,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)","
Received",2020-11-29
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120481,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Revised,2020-12-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120481,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Accepted,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120481,"
(This article belongs to the Special Issue Terpenes – Pharmaceutics and Biotechnology)", Published,2020-12-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120482,"
(This article belongs to the Special Issue Novel Antibacterial Agents)","
Received",2020-11-18
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120482,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Revised,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120482,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Accepted,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120482,"
(This article belongs to the Special Issue Novel Antibacterial Agents)", Published,2020-12-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120483,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)","
Received",2020-11-15
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120483,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Revised,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120483,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Accepted,2020-12-17
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120483,"
(This article belongs to the Special Issue Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids)", Published,2020-12-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120484,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)","
Received",2020-11-24
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120484,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Revised,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120484,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Accepted,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120484,"
(This article belongs to the Special Issue Nano Drug Carriers 2021)", Published,2020-12-21
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120485,"
(This article belongs to the Special Issue Anticancer Drugs 2021)","
Received",2020-11-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120485,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Revised,2020-12-11
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120485,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Accepted,2020-12-16
Pharmaceuticals,2020,13,12,https://doi.org/10.3390/ph13120485,"
(This article belongs to the Special Issue Anticancer Drugs 2021)", Published,2020-12-21
